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A computer model of blood plasma has been used to evaluate the factors affecting the 
ability of a ligand to increase the low molecular weight copper pool in vivo. The justification 
for using this speciation approa~h is based on the assumption that the low molecular weight 
copper complexes are important in the reduction of the inflammation associated with 
rheumatoid arthritis. 
Based on the results of the simulation , two novel ligands, 3,6,9, 12-tetra-azatetradecanedioic 
acid (ttda) and 3,6,9,-triazaundecanedioic acid (dtda) have been synthesised using a three 
step route . Multiple carboxylation was prevented by using the tosylate protecting group. 
The compounds were obtained in an overall yield of 14.7 and 29.0 %, respectively, and 
characterised using n.m.r, l.R. and mass spectrometry. 
The stability constants of the complexes formed by these ligands with several metal-ions 
were determined using glass electrode potentiometry at 25°C and an ionic strength of 0.15 
mol dm·3 . The metals used were the divalent ions of magnesium, calcium, manganese, 
cobalt, nickel , copper and zinc. The values determined followed the Irvine-Williams order 
of stability. 
The stability constants determined were added to the blood model database and the 
expected mobil isation of copper calculated . The two ligands were found to be close in 
mobilising ability, in spite of the higher stability of the ttda complex. This result has been 
rational ised in terms of the relative effect of the competition from the calcium and zinc ions 
for the ligands. The computed values were compar!3d with experimental results obtained 
from ultrafiltration studies. Broad agreement was obtained between the two sets of results. 
For passive transport across a cell membrane, the complex is required to be electronically 
neutral. Evidence for metal-carboxylate complexation in the copper-ttda system was 
obtained from UV/VIS spectroscopy, and in the calcium-ttda system from n.m.r. 
spectroscopy. 
A plausible theory advanced to explain the anti-inflammatory action 'of copper complexes 












complex was assessed using a simple laboratory procedure. A low activity was determined 
for this complex. 
The evidence obtained from the investigations undertaken during the work suggested that 
the copper-ttda complex had p~tential as an anti-inflammatory agent. Animal screens using 
rats in which the adjuvant arthritis model of rheumatoid arthritis had been developed were 
conducted . As the inflammation model was not successfully developed in the animals , no 
conclusions could be drawn as to the possibility of anti-inflammatory activity, but it was 
found that the administered copper was excreted very rapidly via the kidneys. The evidence 
indicates that while the copper-ttda complex remains intact in the blood stream , it is too 
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GLOSSARY OF SYMBOLS 
standard electrode potential. 
total ligand. 
the measured emf of the cell. 
universal gas constant. 
absolute temperature. 
Faraday constant. 
calculated total proton concentration required for observed pH in the absence of 
complexation . 
average number of protons bound to a ligand in the absence of complexation . 
overall stability constant, p = metal; q = ligand; r = proton. 
standard deviation of the stability constants.·· 
crystallographic R-factor. 
ionisation constant of water. 
Absorption at wavelength 'A . 
molar adsorption coefficient at wavelength 'A of the i th species . 
concentration at wavelength 'A of the i th species. 
molar adsorption coefficient at maximum absorption . 
wavelength of maximum absorption. 
number of moles of ligand bound per mole of protein . 
negative log of the deuterium concentration . 
equilibrium constant before ultrafiltration . 
equilibrium constant after ultrafiltration. 
chemical shift. 
fractional population of the /h atom in the various species. 
chemical shifts of the /h atom in the various species. 
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1.1 Rheumatoid Arthritis 
Rheumatoid arthritis is a chronic, debilitating disease of the connective tissue, and is the 
most severe of all the rheumatic diseases. It affects about 5% of the population of the 
western world and is particularly prevalent among the elderly. It is more prevalent in woman 
than in men. A cure has not yet been found . It often occurs first in the knuckle joints , 
appearing as a slight swelling , as shown in Figure 1.1, and is accompanied by stiffness. 
Figure 1.1: Early stages of Rheumatoid Arthritis . 
As the disease progresses the inflammation increases, Figure 1.2, and can be accompanied 
by the progressive degeneration of the joint, caused by the unrestrained inflammation, until 
it is crippled , Figure 1.3. 
A comparison of a normal joint and one damaged by rheumatoid arthritis is given 
schematically in Figure 1.4. 
It may be restricted to the hands, but can spread to other joints, as well as tissue such as 
lungs, skin , blood vessels, muscles and heart. The course of the disease is unpredictable 












Figure 1.2: Later stages of Rheumatoid Arthritis . 
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Schematic representation of the degeneration of a joint affected by 
Rheumatoid Arthritis. 
The etiology of rheumatoid arthritis is not well understood (Rafter, 1982). Clinical evidence 
suggests that several factors together result in the onset of RA, rather then one single 
defect. There is little evidence to suggest that the disease is hereditary. Many theories 
centre on the breakdown of the auto-immune system ( Walker, 1977; Reynolds, 1976). It 
is possible that an anti-inflammatory response to some physical , emotional or hormonal 
stress is not properly regulated by the usual feedback mechanisms, and the irritation 
continues to stimulate itself. 
In Rheumatoid arthritis extensive infiltration of activated polymorphonuclear leucocytes into 
the joint space occurs (Bury et al. , 1988). Activated leucocytes produce superoxide 
radicals , 0 2·, which aid in the destruction of ingested microorganisms. A significant fraction 
of these radicals escapes from the surface of the leucocytes, and in normal circumstances 
intracellular tissue damage is controlled by the superoxide dismutases, a group of enzymes 
that are able to disproportionate superoxide rad icals . However the extracellular 
concentration 6f the enzymes is low and it has been suggested that superoxide rad icals 
may be involved in the depolymerisation of hyaluronic acid and general tissue damage that 
can accompany the inflammatory process . It has also been suggested that release of 
lysosomal proteinases to the extracellular fluid causes degradation of collagen and 












There is a suggestion (Weber, 1984) that a potassium deficiency disrupts the copper 
metabolism of the body, which leads to an inappropriate requirement for copper. In people 
with marginal copper reserves, this demand may be met at the expense of other copper 
dependent enzymes, such as lysyl oxidase and superoxide dismutase. The absence of 
these enzymes can result in.the tissue damage which accompanies rheumatoid arthritis. 
The condition is usually treated with drugs initially. These include non-steroidal anti-
inflammatory drugs (NSAIDs), eg aspirin ord-penicillamine. ·Anti-rheumatoid preparations, 
slow-acting anti-inflammatory drugs (SAARDs) eg gold and immuno-suppressive drugs. 
Cortisone and derivatives are used extensively, and when first used were extremely 
effective. The deleterious side effects of cortisone have, however, limited its use. Gold 
based drugs prevent further degradation, but will not repair damage that has already 
occurred in the joints. They can be toxic to skin, kidney, liver and bone marrow. They affect 
the inflammatory cells and reduce the inflammation;· and reduce the rheumatoid factor. 
In patients with advanced disease, surgery has been successfully used. Knee and hip 
replacement procedures have restored mobility to many sufferers, but these methods of 
treatment are costly. 
1.2 Physiology of copper 
1.2.1 Normal Physiology 
Copper is an essential element in human physiology, and occurs throughout the body. It 
has been established that copper is required for haemoglobin synthesis, growth, 
keratinisation, pigmentation, bone formation, reproduction, fertility, development and 
function of the central and peripheral nervous systems, cardiac function extracellular 
connective tissue formation and regulation of monoamine concentrations (Underwood, 
1977) Copper is deeply involved in a number of biochemical pathways associated with 
inflammation, for example prostaglandin biosynthesis, as well as connective tissue 
metabolism. It is stored in the liver, and released homoeostatically to meet the normal 
requirements of body tissues. Increased copper release occurs in response to many 
disease states (Sass-Kortsak, 1967). 
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1.2.2 Altered physiology of copper in disease 
Altered copper levels have been reported in rheumatoid arthritis (Sorenson, 1978), cancers 
(Hrgovicic et al, 1973) and seizures (Brunia and Buyze, 1972). · Rheumatoid arthritis 
patients have higher mean ser~m or plasma copper concentrations. Concentrations return 
to normal with disease remission. It ihas been suggested that the increased concentration 
of copper-containing compounds indicates a 'putative modulator' role of these compounds 
in inflammation (Bonta, 1977). Normal or low serum copper' concentrations found in some ---- ... , ' 
patients could be due to failure of this mechanism as a result of depleted liver copper 
stores. 
1.3 Copper and,Rheumatoid arthritis 
Several folklore remedies for the treatment of arthritis are associated with copper. These 
include foodstuffs rich in copper, such as shellfish and nuts. Copper jewellery, including the 
copper bangle, are also believed to have beneficial effects in the control of arthritis 
(Whitehouse, 1976). It has been shown that l.m.w. copper complexes liberated from 
albumin by penicillamine are pharrnacoactive ( Whitehouse et al, 1975). 
1.4 Clinical Anti-inflammatory activity 1of copper 
Several reviews have been published on the anti-inflammatory activity of copper complexes 
(Sorenson, 1979 ; Bonta, et al 1980; Sorenson, 198.1 ). It has been suggested that copper 
complexes of clinically used antiarthritic drugs were formed in vivo and that they were 
responsible for the beneficial effects of these drugs ( Sorenson, 1976; Sorenson, 1976; 
Sorenson, 1981). This suggestion was supported by observations that copper complexes 
of many non anti-inflammatory complexing agents had anti-inflammatory activity in animal 
models of inflammation. In a comparison of the effectiveness of copper, gold and silver 
thiomalate and thiosulphate in models of inflammation, the copper complexes were 
effective, while the activity of the gold and silver complexes was much lower. 
Clinical studies conducted from 1940 to 1950 showed various copper complexes to be 













advent of hydrocortisone as an apparent cure for arthritis led to the disuse of the copper 
agents. 
There are several possible mechanisms to account for the anti-inflammatory activity of 
copper complexes. 
a) Induction of Lysyl oxidase 
The repair of damaged tissue requires cross-linking and extracellular maturation of 
the tissue components collagen and elastin. The copper dependent enzyme lysyl 
oxidase is responsible for this process. It has been shown in animal studies that 
lysyloxidase activity can be induced with copper(ll) sulphate (Harris, 1976). 
b) Modulation of Prostaglandin synthesis. 
Copper complexes have been shown to decrease the synthesis of pro-inflammatory 
prostaglandin, PGE2 , and increase the synthesis of anti-inflammatory prostaglandin, 
PGF20 , (Boyle et al, 1976; Vargaftig et al, 1975). Modulation of the biosynthesis by 
·copper complexes is an attractive mechanism for the action of copper. 
c) Induction of Superoxide Dismutase and Superoxide Dismutase-Mimic Activity 
Rheumatoid arthritis has been associated with decreased superoxide dismutase 
activity (McCord, 1974). Superoxide dismutase is known to have anti-inflammatory 
and antiarthritic activity (Huber and Menand~r-Huber, 1980)~ Many of the copper 
complexes studied have SOD like activity. 
d) Stabilisation of Lysosomal Membrane 
Copper is reported to decrease the permeability of human synovial lysosomes, thus 
decreasing the release of free lysosomal enzymes (Chayen et al, 1969). 
e) Modulation of histamine 
The modulation of the physiological effects of histamine may also be an important 
biochemical role for copper. There is evidence to support the suggestion that a 













The evidence presented in the literature suggests that there is a localised deficiency of 
copper, which is associated with the disease (May and Williams, 1978). As most of the 
serum copper is non-reversibly bound to ceruioplasmin, the fraction of copper which will be . 
concerned with a localised deficiency is the labile component comprising the albumin and 
low molecular weight (l.m.w.) bound copper and the free metal ions. The l.m.w. fraction is 
thought to be important in the transport of metal ions across cell membranes and between 
biological sites (May and Williams, 1978). Their role in biological systems is not easy to 
investigate, as the concentration of these complexes is generally below the detection limits 
of available analytical techniques, and the equilibria would be disturbed by attempts to 
concentrate and extract the components for analysis. The concentration of ionic copper in 
plasma has been estimated to be approximately 10-20 mol dm-3 (May, Linder, and Williams, 
1977). Copper thus occurs primarily in complex form. 
A reliable way to overcome this analytical limitation is to use computer simulation to model 
the distribution of the metal ions in the plasma, and to determine the important complexes 
present under plasma conditions. A blood plasma model developed by May et al (May, 
Linder, and Williams, 1977), has been successfully used to account for several processes 
in drug therapy. The model requires the thermodynamic formation constants for the 
complexes present in plasma, as well as the overall component concentrations. Although 
the metal ion - protein interactions have not been fully characterised, it is possible to use 
these calculations to investigate aspects of the copper equilibria in the low molecular weight 
fraction. 
The design of a therapeutic generally requires knowledge of the difference between the 
health and diseased state at a molecular level. Alt~ough there is no clear understanding 
of this in the case of rheumatoid arthritis, the observed effect of copper on the inflammation 
associated with the disease provides a basis for drug design. This approach is based on 
·.two assumptions. Firstly, the therapeutic effect of copper arise from an increase in the total 
labile copper concentration in body compartments such as the synovial fluid, and secondly, 
this increase is aided by the formation of complexes in plasma that can diffuse through the 
separating membrane into the synovial fluid. This can be achieved by simply increasing the 
labile copper concentration in the plasma, The most straight~forward way of administering 
the copper is by injection, but this is unfortunately associated with several undesirable side 
effects. The increase in the local concentration of copper complexes may be achieved by 
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excreted in urine 
. Neutral complexes 
(hydrophobic) 
deposited in tissue 
Routes for increasing the concentration of l.m.w. copper complexes in blood 
plasma 
The one is based on the liberation of endogenous reserves, the other on copper 
supplementation by oral or topical administration. 
For short term therapy endogenous rather than exogenous sources seem appropriate. 
There are three ways of achieving this aim. 
• By equilibrium competition for the labile protein-bound copper. 
• By decreasing the affinity of serum albumin for copper by allosteric effects 













1.5 Objectives of the research 
The research presented above indicates that increasing the local concentration of l.m.w. 
copper complexes (May and Williams, 1978) by means of an externally administered ligand 
could be effective in relieving the symptoms of rheumatoid arthritis by stimulating anti-
inflammatory activity. It is also possible that the copper complex of this ligand may act in 
some way against rheumatoid arthritis. The broad objectives of this research were to 
develop and investigate such a ligand, using the following methodology. 
• To use computer simulation techniques to design a ligand that would facilitate the 
exogenous administration of copper(ll). The ligand would have to be highly 
selective for copper(ll) so that it did not disturb the in vivo distribution of other metal 
ions. It would also need to form a neutral complex with copper under in blood 
plasma conditions, in order to enable passage across the cell membrane. 
• Synthesise representative ligands which were designed in stage one. 
• Measure the formation constants of these ligands with copper(ll) and the two most 
common blood plasma metal ions, zinc(ll) and calcium(ll). 
Use a computer model of blood plasma, together with the measured equilibrium 
constants, to evaluated the plasma mobilising ability of the studied ligands. 
Substantiate the computer simulation results using ultra-filtration. 
• Study the structure of the copper complexes with the selected ligands in solution 
using UV/VIS spectroscopy. 
• Measure the SOD activity of the copper complexes with the selected ligands using 
a simple in vitro assay. 
• Finally, study the anti-inflammatory activity and toxicity of the most promising 
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The investigation of large chemical systems such as the sea, lakes, aquifers and biological 
fluids is difficult due to their complexity and the extremely low concentrations of the 
constituents. The analytical techniques currently used perturb the system (May, Linder and 
Williams, 1976) and do not provide information about the distribution of the components 
amongst the various forms in which it occurs. 
Simulation of the system is one of the techniques that has been used to investigate these 
systems. Early examples of this technique are the studies on seawater by Sillen (Sillen, 
1967), and blood plasma by Perrin and co-workers(Perrin, 1965; Hallman, Perrin, and Watt, 
1971). While limitations to this approach exist in the form of inadequate description of the 
system, lack of thermodynamic and kinetic data to describe the reactions taking place and 
the extent and accuracy of component analysis (Jenne, 1979), it is an effective way to 
increase the understanding the chemistry of the system and of the factors that may 
influencing it. The use of high speed computers has enabled workers investigating such 
systems to use larger and more representative models. 
2.2 Speciation modelling 
In biological systems there are many aspects that need to be considered. In multicellular 
organisms the solutions on either side of the cell membrane are usually different. An 
example of this could be the gastric juices in the stomach, which are at a low pH, while that 
of the cells lining the stomach are near neutral pH. These differences influence the 
chemistry and hence the bioavailability of metal ion~. 
The bioavailability of a species such as a metal ion varies, depending on the type and 
concentration of ligands in that solution (Sandstead, 1988). 
The design of drugs has been dominated by a 'black box' approach, in which numerous 
compounds were screened in the hope of finding an active substance. As this approach 
is expensive and time consuming, alternative methods have been employed. These include 
structure activity relatiohships, and molecular modelling approaches when the mechanism 
of action is known. These methods are not particularly successful where labile metal 
complexes are concerned, as the active substance may not bear any relationship to the 
administered drug. An alternative approach to this problem, speciation design, has 
developed out of speciation modelling of biological systems. 
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The essential feature of speciation models is to define a series of chemical equilibria, which 
represent as complete a description of the equilibria in the system under investigation as 
possible. This series of equilibria, together with the concentrations of all components in the 
' 
system constitute the data base of the model. Computer models exist which can interrogate 
such databases, and solve for individual species concentrations. 
Such models are often criticized because they are generally incomplete due to limitations 
of our understanding of complex systems, such as blood· plasma. However, provided 
cognisance is taken of the restrictions, useful information can still be extracted from the 
models. 
One limitation of present day speciation modelling is that no account is taken of the kinetics 
of the system. The system is assumed to be at equilibrium, which is rarely the case in 
biofluids. In cases where the complexes are kinetically inert, even though it is predicted that 
at equilibrium the metal ion would be redistributed amongst the available ligands, in reality 
the complex is excreted before significant redistribution can occur. 
Since speciation modelling is a quick and relatively easy way of predicting the in vivo 
· distribution of an administered ligand or complex, it is a useful tool in the design of new 
drugs aimed at influencing the distribution of metal ions. In this process the metal ion 
coordinating characteristics of a ligand are varied and the effect of these changes on the 
metal ion speciation are calculated using an appropriate model. 
2.3 Blood plasma model 
The blood plasma model used in this study was developed by May et al (May, Linder and 
Williams, 1977). This model includes data for 10 metal ions and 43 ligands, giving rise to 
nearly five thousand equilibria. The model also includes the important ternary complex 
equilibria. This database is efficiently and conveniently interrogated by the ECCLES 
computer program. 
One limitation of the model, or in fact a deliberate omission of the model, are protein 
equilibria. Metal-protein equilibria are ill-defined, and cannot be effectively included ''in 
simulation models. For this reason the model uses the concept of a plasma mobilising 
index, P.M.I., to obtain results that are largely independent of the protein equilibria (May and 
Williams, 1977). In this approach the distr!bution of the metal ions in the low molecular 












absolute concentration of the metal ions is dependent on the extent of protein binding, the 
distribution amongst the l.m.w. ligands is not. Owing to the very low free metal 
concentration, the amount of complex formed is negligible in comparison to the ligand 
concentration. Consequently the free ligand concentrations are also not significantly 
· affected, they are 'concentration buffered'. Under these circumstances the concentrations 
of the complexes are dependent only on the free metal concentration. As this is the case 
for all mononuclear species, the total concentration of each metal in the l.m.w. fraction is 
also dependent on the free metal concentration. The percentage of metal appearing in a 
given species is constant, regardless of the exact free metal concentration, and is therefore 
independent of the metal-protein equilibria that determines the free metal concentration. 
The ability of different administered ligands, drugs in this case, to move a metal ion from the 
protein bound.fraction to the l.m.w. fraction can be expressed as a Plasma Mobilizing Index 
(P.M.I.), which is defined as: 
P.M.I. = 
Total concentration of l.m.w. metal complex species in the presence of the drug 
Total concentration of l.m.w. metal complex species in normal plasma 
It is the l.m.w. fraction of copper that is postulated to be involved in the transport of the ion 
across membranes and between active sites, and it is this fraction that can be most 
effectively manipulated in an attempt to increase the availability of copper to anti-
inflammatory processes. 
2.4 Ligand design 
As outlined in Chapter One, the design of copper based anti-inflammatory drugs is based on 
the assumption that (a) their therapeutic effect arises from an increase in the total labile 
l.m.w. concentration of copper in the inflamed tissue and (b) that the labile concentration may 
be increased by an increase in the tissue permeable neutral fraction of copper in plasma. 
In thermodynamic terms what is required is a strong dianionic chelator which is specific for 
copper, as it must be effective in competition with in vivo metal ions and ligands. Ultimately 
the only way of testing a drugs efficiency is with animal screens, but we can carry out 
preliminary in vitro assessment with computer modelling. It is not sufficient to just compare 
the equilibrium constants of the different possible drugs, as this does not make allowances 
for competition from other ligands and metal ions. The danger of ignoring this competition 












in l.m.w. copper. The introduction of zinc into the model, at its physiological concentration, 
decreases the mobilizing ability of edta by a factor of 105 . The effect of Ca+2 is even more 
dramatic. The reason for these effects is that , although the [Cu(edta)]2- complex is more 
stable than the zn+2 and Ca+2 complexes, the in vivo concentrations of these two metal ions 









Figure 2.1 : 
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The effect of Ca+2 and zn+2 upon the Cu+2 Plasma Mobilizing Index of edta 
Speciation modelling can simulate the effect of structural changes of a ligand on its ability to 
mobilise copper in plasma. In order to achieve this simulation , the structural features of 
ligands which would influence the strength or selectivity of complexation with copper were 
identified, and several ligands selected which contained these features . The stability 
constants of these ligands were extracted from the literature, or estimated if they were not 
available, and added to the blood plasma data base. The influence of these features on the 
l.m.w. concentration of copper was then assessed by calculating the P.M.I. over a range of 
ligand concentrations . 
Donor atom 
The first structural feature considered in the design of the ligand is the donor atom. Copper 












important competitor metal ions in plasma, Zn(ll) and Ca(ll) , are both hard, so a soft donor 
ligand should favour copper. As the atom changes from 0 to S to N, the mobilizing 
efficiency of the ligand increases dramatically- the nitrogen analogue being 106 times more 
efficient than its sulphur counterpart, Figure 2.2. Note that the thiol group, which is known 
to form very stable copper complexes, was not considered for two reasons. Firstly, the 
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Figure 2.2: The effect of the donor atom upon the Plasma Mobilizing Index of cu+2 
Donor strength 
The strength of the ligand is measured by its basicity. Several N,N'-disubstituted 
ethylenediamine compounds were used to examine the effect of the nitrogen ligand used. 
A comparison of 2-aminobenzyl-, 2-methyleneimidazolyl-, 4-methyleneimidazolyl-, 2-
methylenepyridyl- and 2-aminoethyl-substituents (referred to in the Figure as An, 2-imid, 4-
imid, py and amine, respectively) is shown in Figure 2.3. 
2-aminobenzyl is understandably poor, but in view of the wide biological use of histidine as 
a chelating agent, it is surprising how poorly 4-methyleneimidazolyl performs. Under 
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copper. Unfortunately, the situation is not as simple as shown because the site of 
substitution is also important. 
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The effect of the site of substitution is shown in Figure 2.4, using pyridine as the substituent. 
Substituting the central amino group with pyridine results in a decrease in mobilisation , 
whereas substitution at the terminal groups increases the mobilization. 
Number of donor atoms 
Since our ligands are all chelate ligands, the question of denticity arises. Figure 2.5 shows 
the effect of changing the number of coordinating atoms. The large increase in mobilization 
in going from mono- to bidentate reflects not only the increased stability of the copper 
complex, but also the increased difference in stability between the Ca2+ and Cu2+ complexes . 
Above a coordination number of 4 there is no significant increase in mobilizing ability. This 
is because copper complexes are generally Jahn-Teller distorted, so the addition of the fifth 
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Figure 2.5: The effect of the coordination number upon the Plasma Mobilizing Index of Cu+2 
Ring size 
The effect of ring size is illustrated in Figure 2.6, using a quadradentate ligand as an 















and , as expected , is far less effective at mobilizing copper than 
H2N(CH2hNH(CH2) 2NH(CH2)JNH2 , which gives rise to one 5-membered ring and two 6-
membered rings upon coordination. Triethylenetetramine, which forms three 5-membered 
rings upon coordination is 1000-fold more efficient at mobilizing copper. The introduction of 
one 6-membered ring in the middle of the ligand results in a substantial increase in the 
copper mobilizing index, presumably as a result of decreased ring strain within the complex. 
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Figure 2.6: The effect of ring size upo:i the Plasma Mobilizing Index of cu+2 
Anionic groups 
Since we wish to form a neutral Cu2+ complex, the ligand has to contain two anionic groups. 
In Figure 2.7 the effect of phosphonate, phosphate , carboxylate and phenolate is compared . 
There appears to be little to choose between the last three groups, which are all more 
efficient than phosphonate . Since each phosphate is dianionic, we should really consider the 
monoester of the ' phosphate in order to form a neutral complex. Interestingly, methyl 
substitution increases the efficiency 10-fold . This is probably due to the inductive effect of 
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The effect of the anionic substituents upon the Plasma Mobilizing Index of Cu+2 
Based on the results of the computer simulation studies, the characteristics giving rise to a 
thermodynamically desirable mobilising agent for copper are a linear, diphenolate, 
dicarboxylate or dialkyl phosphate substituted polyamine. While a dianionically substituted 
macrocycle would also have satisfied these thermodynamic conditions, they are unacceptable 
on kinetic grounds (Jones, 1985). 
This last point illustrates one of the limitations of computer modelling. The absence of kinetic 
data from the model can produce misleading results .in situations where kinetics has a large 
influence on the equilibrium. The interpretation of the results must also include a critical 
analysis of the effects of other chemical influences. 
2.5 Ligand selection 
From the characteristics identified above, a number of possible ligands were considered. 
Two were selected for investigation, these being ttda and dtda. The structural formulae are 
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The results of the computer simulation, described in Chapter 2, indicated that an unbranched 
aliphatic polyamine containing 4 amino groups would be a strong coordinator of Cu(ll) under 
in vivo conditions. Further, it was shown that a ligand which formed a 5,6,5 or a 5,5,5 chelate 
ring system in metal complexation would have considerably enhanced stability. It was also 
necessary that the ligand would form a neutral complex with divalent metal ions. This 
requirement dictated that the anionic groups themselves would have to coordinate with the 
metal at pH 7.4. The computer simulation results did not give a definite indication of 
superiority between any of the tested anionic groups, so the carboxylate group was chosen, 
as this group was more accessib le synthetically. 
As this study was intended to be part of an ongoing project, the synthetic approach selected 
needed to be versatile . This would allow developmeri·t of the structure of the target ligand, as 
the work progressed, without requiring extensive modification of the synthetic route. 
Two ligand structures chosen as target molecules were 
(I) (dtda) 
(I) being a dicarboxylate derivative of diethylenetriamine, and (II) a dicarboxylate derivative 
of triethylenetetramine. 
The use of the sulphonate ester as a leaving group in organic synthesis is well known 
(Morrison and Boyd, 1973) and the p-toluene sulphonate group was used extensively in 
protein synthesis until the appearance of more efficient protecting groups. These two uses 
of this group have been combined (Richman and Atkins, 1974; Hart, Boeyens, Michael and 
Hancock, 1983; Koyama and Yoshino 1972) in the synthesis of varying size heterocycles. 
Generally, bisulphonamide sodium salts were condensed with the required compound 
containing the sulphonate ester leaving group. 
The first attempt to synthesise the target molecules used an adaptation of this general 
procedure. The appropriate aminoalcohol was converted to the sulphonate ester (tosylate) , 
by reaction with p-toluenesulphonyl chloride. At the same time the sulphonamide was 















a 2 molar equivalent of the sodium salt of the sulphonamide derivative of glycine. This was 
a particularly attractive scheme, as many amino acids are readily available commercially. 
Unfortunately repeated attempts fai led to produce the required product. 
The approach was changed , and the sodium salt of the sulphonamide derivative of the 
required polyamine (trien or di.en) was condensed with ethyl bromoacetate. The resulting 
compounds are thus the sulphonamide derivatives of the ethyl esters of the target molecules. 
Removal of the sulphonamide protecting group proved elusive. Several methods were tried , 
sodium in liquid ammonia (Kovacs and Ghatak, 1966), 96% sulphuric acid (Richman and 
Atkins , 197 4) , heating under pressure in concentrated HCI (Fabbrizzi, Bencini , and Poggi , 
1981) and 47% HBr in glacial acetic acid (Koyama and Yoshino 1972) without any apparent 
success. A modification of the method used by _Hashell and Bowlus (Haskell and Bowlus , 
1976), in which the tosyl groups were removed by prolonged heating under reflux with 
HBr/glacial acetic acid , gave the hydrobromide of the target compounds . 
The three step synthetic route is given in Scheme 1 below: 
0°C 




20% HBr I glacial acetic 
tJ. 
1. x = 1 
2. x = 2 
3. x = 2 
4. x = 3 
5. x = 2 
§. x = 3 













At each stage of the synthesis of the two ligands, ttda and dtda, the products were fully 
characterised using l.R. and n.m.r. spectrometry. Micro analysis and melting points were 
also determined and found to be satisfactory. 
As the preparation of the two ligands is similar, only the details for ttda will be given. The 
data for the preparation of dtda are summarised in Table 3.2. 
3.2 .1 Preparation of Triethylenetetraminetetra-p-toluene sulphonamide: 
10.25g (0.07mol) of trien was placed in a 1 litre flask. 11.22g (0.28mol) of sodium hydroxide 
was dissolved in 200ml of distilled water in a beaker. The solution of base was added to the 
amine, and the reaction vessel placed in an ice water bath . The mixture was stirred 
vigorously with a mechanical stirrer while 55g (0.288mol , required 53.4g) of 
p-toluenesulphonylchloride in 300ml of ether was added drop wise over approximately 6 
hours. Stirring was continued fo r a further 2 hours after the addition was complete. The 
mixture was kept at <5° C throughout the reaction . The gummy white precipitate was 
collected by filtration and washed with ethanol. The product was refluxed with ethanol for 
one hour, and cooled . The fine white product was collected by filtration , washed with 
ethanol and air dried . The product was recrystallised from an ethanol/pyridine mixture. This 
preparation was carried out three times for a combined yield of 67.7g , 42 ,4% overall. The 
data are summarised in Table 3. 2. 
3.2.2 Preparation of the ethyl acetate derivative 
Sodium hydride (0.6g , 0.01 Smol , req 0.55g) , was suspended in 200ml of freshly dried THF 
in a large nitrogen flushed round bottom flask. The sulphonamide (7.0g, 0.0092mol) was 
added to the suspension and allowed to stir for 2 hours. A pasty solid resulted . Using a 
cal ibrated syringe , ethyl bromo acetate (2 .1 ml , 0.019mol , req .01 Smoles) was added 
dropwise. The mixture was stirred for an additional 3 hours , giving a pale yellow solution 
with a fine white suspension (probably NaBr) . As the suspension was too fine to filter, the 
reaction mixture was centrifug ed at 2500 rpm for 1 hour, and the supernatant liquid 
removed. The sol id was washed with THF and centrifuged several times . The washings 
were added to the original supernatant solution . The volume of the reaction mixture was 
reduced to approximately 50ml , giving a viscous yellow solution . Hot ethanol (120ml) was 












precipitated as fine white crystals on cooling . At this stage it was necessary to exercise 
some care, as the addition of an excess of water gave an oil, and this adversely affected the 
yield . The precipitate was collected by filtration , and recrystallised from ethanol. The 
reaction was repeated several times to give a combined yield of 54.1g, 79.0%. 
The data are summarised in Table 3.2. 
3.2.3 Hydrolysis of the p-toluenesulphonyl protecting group. 
An approximately 20% m/m HBr in glacial acetic acid solution was prepared by bubbling HBr 
gas, produced by reaction of bromine with tetralin (Vogel , 1956, p 182), through glacial 
acetic acid . The ethyl acetate derivative of the sulphonamide (2 .5g) was added to 250ml of 
the HBr/glacial acetic acid solution . The solid dissolved to give a light yellow solution , which 
turned red after about one hour. The solution was refluxed for 60 hours , after which the red 
solution contained a cream-coloured precipitate. The volume was reduced on a rotary 
evaporator and then poured into 200ml of dry diethyl ether with agitation. The mixture was 
cooled and the precipitate collected on a fine glass frit. The product was recrystallised 
several times from 90% ethanol and concentrated hydrochloric acid, yielding a fine white 
microcrystalline solid . The reaction was performed several times for a combined yield of 
12.6g , 64%, of the tetra hydrochloride of ttda. A yield of 12.6g represents an overall yield of 
14. 7% , based on the tota l mass of trien used (30.6g) . 












Table 3.2: . Data of the synthesis of ttda and dtda. 
Compound formula Yield(%) Micro analysis(%) m.p. (°C) 
c H N 
C34H42N4S40 8 42.4 calc.: 53.52 5.54 7.34 212-215 
found : 53.5 5.45 7.35 
C42Hs4N4S40 12 79.0 calc.: 53.94 5.82 5.98 135-138 
found : 53 .85 5.75 5.95 
C10H26 N40 4C14 64.0 calc.: 29.42 6.42 13.73 163-177 
(ttda.4HCI) found: 29.3 6.4 13.6 (decomposition) 
Overall yield 14.7 
C2sH31 N3S30 6 65.5 calc.: 53 .07 5.52 7.43 177-178 
found : 53.2 5.7 7.5 (lit 173; Peacock and 
Dutta , 1934) 
C33H43N3S30 10 74.0 calc.: 53 .71 5.87 5.69 98-101 
found: 53.45 5.9 5.7 
C8H 20N30~Cl3 59.9 calc.: 29.24 6.14 12.79 137-150 
(dtda .3HCI) found: 28.9 6.3 12.6 (decomposition) 
Overall yield 29.0 
3.3 Spectral assignment 
The spectroscopic data pertaining to the intermediate compounds , as well as for ttda , are 
summarised in Table 3.3. 
In the Ir spectrum of this compound the C=O stretch shifts to 1738 cm-1, which compares well 
to the C=O stretch at 17 40 cm-1 for the hydrochloride salts of edda and edta reported by 
Kawato et al (Kawato, Kanatomi and Murasc, 1973). For a similar molecule, with the acetic 
acid residues at N2, N3, the C=O stretch was reported at 1720 cm-1, supporting the site of 
substitution of this molecule as N1, N4. The N-H stretch arising from a secondary amine salt 
occurs as a broad peak between 2931 and 2970 cm-1. Several spikes at 2382, 2429, 2458 
and 2502 confirm a secondary amine hydrochloride salt (lgi , 1975; The Aldritch Library of 
infrared Spectra , 1981). 
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Table 3.3: · Summary of the spectral data for ttda 
Compound o (ppm) multiplicity integration assignment 
N4Ts4 2.22 singlet 9H ArCH 3 
(In pyridine-d5) 3.60 singlet SH R-CH2-R 
3.37 singlet 4H R-CH2-R (central) 
5.64 broad singlet 1.3H N-H (removed by 020 wash) 
7.73 multiplet 12H ArH 
Wave no. (cm-1) intensity bond assignment 
3275 s N-H stretch R-NH 
1600 I m I C=C stretch Ar 1492 m 
1360-1250 m C-H bend RR'C-H2 
Compound o (ppm) multiplicity inte.gration assignment 
N4Ts4(EtAch 1.15 triplet 6H EtCH3 
(CDCl3 , ref TMS) 2.42 singlet 12H ArCH 3 
3.30 singlet 4H RR'CH2 (central) 
3.42 singlet SH RR'CH2 
4.04 I quartet I SH acetate CH2 4.06 singlet EtCH2 
7.54 multiplet 16H ArH 
Wave no. (cm-1) intensity bond assignment 
1748 s C=O RCOOR' 
1213 m C-0 RCOOR' 
1030 m C-0 RCOOR' 
Compound o (ppm) multiplicity integration assignment 
ttda (4HCI) 3.60 Singlet 12H Ethylene CH2 
(020) 4.00 Singlet 4H Acetate CH2 
Wave no. (cm-1) intensity bond assignment 
3175 w 0-H stretch RCOO-H 
2970-2931 s N-H stretch RWH2 
2502-2382 m WH2CI salt 
1738 s C=Ostretch RCOO-H 
1226 m C-0 stretch RCOO-H 
1091 m C-N stretch RC-N 
747 m(broad) N-H wag RR'WH, 
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The spectroscopic data for dtda is presented in summary in Table 3.4. 
Table 3.4: Summary of the spectral data for dtda 
Compound o (ppm) multiplicity integration assignment 
N3Ts3 2.26 singlet 9H ArCH 3 
(I n pyridine-d5) 3.64 singlet SH R-CH2-R 
7.69 multiplet 12H ArH 
Wave no. (cm-1) intensity bond assignment 
32SS s N-H stretch R-NH 
3060-3040 s C-H stretch ArC-H 
3000-2S50 s C-H stretch RR'C-H2 
1597 I m I 
C=C stretch Ar 
1493 m 
1340-1305 m C-H. RR'C-H2 
Compound o (ppm) multiplicity integration assignment 
N3Ts3(EtAch 1.15 triplet 6H EtCH3 
(In CDCl3 ref TMS) 2.40 singlet 9H ArCH 3 
3.40 singlet SH RR'CH2 
4.06 I singlet I SH acetate CH2 4.06 quartet EtCH2 
7.52 multiplet 12H ArH 
Wave no. (cm-1) intensity bond assignment 
1753 s C=O RCOOR' 
1211 m C-0 RCOOR' 
1054 m C-0 RCOOR' 
Compound o (ppm) multiplicity integration assignment 
dtda (3HCI) 3.60 Singlet SH Ethylene CH 2 
4.04 Singlet 4H Acetate CH2 
Wave no. (cm-1) intensity bond assignment 
3149 w 0-H stretch RCOO-H 
297S-2931 s N-H stretch RWH 2 
2779 s C-H stretch RR'CH2 
2462-23S1 m WH 2CI salt , 
1739 s C=Ostretch RCOO-H 
1222 m C-0 stretch RCOO-H 
1070 m C-N stretch RC-N 
745 m(broad) N-H wag RR'WH 7 
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The chemicals used in the reacti ons are listed in Table 3.1 below. 
Table 3.1: Starting materials for the synthesis of ttda and dtda. 
I Chemical I Source I PuritZ'. I Comments 
Trien Merck Technical 70% purified by distillation under vacuum. 
Dien Fluka Technical 96% purified by distillation under vacuum. 
Na OH Saarchem Analar 
p-Toluenesulphonyl Merck Technical Used without further purification 
chloride 
Sodium Hydride Merck 80% Suspension in oil 
Ethyl Bromo Acetate - - Prepared in these laboratories. 
(Vogel 1956, p 429) 
Tetralin Saarchem Unilab 99% 
Bromine Saarchem Unilab 99% 
The solvents used for the preparations were of laboratory grade or better, and those used 
for purification were of analytical grade. T.H.F was dried by reflux over sodium wire under 
nitrogen and transferred directly into the reaction flask under a stream of nitrogen . 
1 H and 13C n.m.r. spectra were recorded on a Varian. XL200 Fourier Transform instrument. 
Chemical shifts are given in p.p.m with T.M.S. (o scale) as internal reference. When some 
other internal reference was used, the chemical shifts were adjusted to correspond to T.M.S. 
Infra red spectra were recorded on a Perkin Elmer 983 instrument as nujol and HCBD mul ls 
between KBr plates. The spectra were recorded between 4000 and 500 cm·1 . 
Low resolution mass spectra were recorded on a V.G. Micromass 16F spectrometer 
operating at 70eV with an accelerating voltage of 4kV. The unprocessed mass spectrum 
was also recorded as a U.V. trace on an EM1 SE6150 UV oscillograph so that metastable 
peaks could be observed. 
Melting points were determined on a Kofler hotstage microscope and are uncorrected. 
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In the study of metal ion equilibria in biological systems, the use of stability constants 
provides a ready means of estimating the speciation of the metal ion of interest within the 
system. 
If some care is taken, comparison of the values of the constants for the equilibria of interest 
with those of similar compounds can provide information concerning the binding and 
structure of the complexes formed. 
In this study there were two purposes in measuring the stability constants for the ligands 
synthesised . 
Firstly the measured constants would be used as input to the blood plasma model , and the 
P.M.I. calculated for the ligands. 
Secondly some knowledge of the complex chemistry of these ligands would be gained. 
4.2 Theory 
The general theory of formation constants and the techniques used to determine them is 
covered extensively in the lite ature (Rossetti and Rossetti, 1961; Beck, 1970; Martell and 
Motekaitis, 1988). A brief description will be given here to define the terms and to outline the 
procedures used. 
For the typical reaction below, the equilibrium constant is defined as the ratio of activities 
of the products and reactants of a reaction at equilibrium (eqn 4.1) 
aA + bB ""' cC + dD 
(4.1) 
The difficulties associated with the determination of activities has lead to the wide spread 
use of concentration, or conditional, constants, where the equilibrium is studied in a large 












aA + bB ""' cC + dD (4.2) 
In terms of metal-ligand equilibria , the complexation can be described by the following set 
of reactions 
M + L""' ML 






Comparison of these stoichiometric constants , when measured under the same conditions 
then becomes meaningful. 
The equilibria represented by equations 4.3 and 4.4 can also be expressed as overall 
formation constants , denoted by ~ . and these are given below. The charges of the species 
have been om itted . 
ML+ L""' ML 
_ [ML] 
~1 = K1 [M][L] (4.5) 
ML + 2L""' ML2 (4.6) 













The possibility of formation of protonated, hydroxo or oligonuclear complexes can be 
depicted by the subscripts of~- In this work, the subscripts follow the order of metal , ligand , 
proton. So for the complex MplqHr the formation constant will be given by 
(4.8) 
When r = -1 this refers to a proton removed to a water mo·lecule or to a hydroxide ligand 
added. 
Any method which can determine the concentration of at least one of the species in the 
equilibrium with reasonable accuracy can be used to obtain the equilibrium constant (Martell , 
and Motekaitis, 1988). Potentiometry is one of the most convenient and widely used of the 
techniques. The glass electrode, which measures hydrogen ion concentration (activity) , is 
widely used, although metal ion selective electrodes are also used. 
At any point in a titration the total concentration of a component is given by the sum of the 
concentrations of all species containing that component, including the free concentration . 
For example the total ligand concentration , TL will be given by: 
TL= [L] + [ML] + 2[ML2J + .... . (4.9) 
And in general by: 
p Q R 
TL = [L] + LL L ~pqr[MJPq[L]q[HY 
p =1 q =1 r =O 
(4.10) 
There are three mass constraints in terms of total ligand, total metal and total hydrogen ion 
concentrations . The total ligand, total metal and total hydrogen ion concentrations are 
known, the free hydrogen ion concentration is measured at each point in the titration, and 
the ~s. free metal and ligand concentrations are the unknowns which must be calculated 
from the mass balance equations. If there are nP titration points and nMsE. mass balance 
equations at each point, there will be a total of nP x nM.B.E free concentrations . As the free 
hydrogen ion concentration is known at each point, there will be nc = np(nM BE - 1) unknown 
free concentrations. If there are m unknown ~s . there will be a total of nc + m parameters 












The hydrogen ion concentration is obtained from the emf readings delivered by the glass 
electrode according to the following equation : 
E E E E o RTln{H +} cell = r + I + g + 
F 
Where: 
Ecefl = the measured emf of the cell 
Er = contribution arising from the reference electrode 
E, = contribution arising from the liquid junction 
£
9
° = Standard glass-electrode potential at unit activity 
R = universal gas constant 
T = absolute temperature 
F = Faraday constant 
{W} = Hydrogen ion activity 
(4 .11 ) 
If the ionic strength of the test solution is kept constant, the hydrogen ion activity can be 
expressed as a concentration , equation 4.12 can be obtained by putting s = 2.303RTIF and 
collecting together all the constants as Econst : 
Ece// = E cons t + S log[H1 (4.12) 
4.3 Data analysis 
Computer analysis of equilibrium data has replaced the graphical methods used earlier, and 
many programs exist to analyse potentiometric data (Martell and Motekaitis , 1988). In this 
study, the program MAGEC (Williams, May, Linder and Torrington , 1982) was used to 
calibrate the electrode and to determine the value of pf<w. Extensive use of features within 
the ESTA (Murray and May, 1984) suite of programs was made to model the equilibria in the 
test solutions and to compute the Ps. 
In the optimisation section a Gauss-Newton least squares method is used to minimise the 
objective function , U, given by 
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N = total number of experimental titration points 
ne = total number of electrodes (one in this study) 
wn; =weight of i1h residual at nth point 
y ni = either T ni = total concentration of electrode ion i at the nth titration point 
or En; = emf of electrode i at the nth titration point 
(o =obs., c = calc.) 
Use was made of the z function, the average number of ligands attached to the metal , 
which is given below. 
z = = I i ~; [Lf (4.14) 
This definition of the function applies only to mononuclear binary complexes . A plot of 
z against-log [L], pl, gives a pictorial representation of the equilibria. If only mononuclear 
binary species are formed in solution , the titrations performed under different conditions of 
concentration and concentration ratios of the metal and ligand should give overlapping 
curves . Any deviation from this is an indication that there are species other than 
mononuclear binary complexes present. This can assist with the selection of models for the 
refinement process . 
As the curve is characteristic of the equilibria existing in the solution , a test of the validity of 
the refined model is to generate a set of titration data using the determined formation 
constants and experimental titration conditions and to construct a Z plot using this data. 
The degree of agreement between the experimental plot and the simulated plot is an 
indication of the validity of the proposed chemical model. This process is termed 
pseudoplotting (Vacca, Sabatini and Gristina, 1972). 
The deprotonation function , Q , is the average number of protons released per metal ion , 
as a result of complexation and is defined according to equation 4.15, where TH and TM· are 
the total proton and metal concentrations respectively ; 
(4.15) 













is the calculated total concentration of protons that would be necessary to give rise to the 
observed pH if no complexation took place. The summation is over all protonated species. 
In order to evaluate T w it is necessary to solve for the free ligand concentration using 
equation 4.17. If we define a formation function for the ligand subsystem according to 
equation 4.18, then F, the average number of dissociable protons in a complex (assuming 
that it is the predominant complex), is given by equation 4 .19. 
(4.17) 
ri = (T w - [H] + [OH])/T u (4.18) 
F=qxri- Qxp (4.19) 
Here Q represents the average number of protons released from the ligand as a result of 
complexation , while ri is the average number of protons whict1 would be bound to the ligand 
in the absence of metal complexation . The difference between the two therefore gives the 
average number of dissociable protons remaining on the ligand after complexation. Clearly, 
cognizance of metal-ligand stoichiometries has to be taken . 
4.4 Results and interpretation 
The protonation and formation constants determined for the systems studied are given in 
Table 4.1. 
Table 4.1 Log p for the species MpLqHr at 25°C and l=O, 15 M NaCl . 
I L 
ttda 
M = Metal 2+ ion , L = Ligand , H = W , a = standard deviation in log constant, 
n = number of titration readings for each system, R is the crystallographic R-factor. 
I M I f2 9 r I log p I a I n I R I 
H+ , 0 1 1 9.766 0.002 800 0.003 
0 1 2 18.603 0.004 
0 1 3 24.947 0.007 
014 28.09 0.01 












I L I M I pqr I log P I a I n I R I 
Mg 2+ 1 1 0 2.34 0.003 779 0.004 
1 1-1 -8.54 0.04 
Ca 2+ 1 1 0 3.17 0.007 216 0.008 
1 1-1 -8.19 0.04 
Mn 2+ 1 1 0 9.47 0.006 214 0.01 
1 1-1 0.048 0.054 
Co 2+ 1 1 0 15.977 0.0064 243 0.005 
1 1 1 19.72 0.01 
Ni 2+ 1 1 0 19.59 0.007 184 0.004 
1 1 1 22.35 0.01 
Cu 2+ 1 1 0 21.34 0.02 140 0.0024 
1 1 1 24.92 0.01 
1 1 2 26.67 0.04 
Zn 2+ 1 1 0 15.65 0.004 112 0.004 
1 1 1 19.14 0.02 
dtda 0 1 1 9.662 0.002 672 0.0028 
012 18.097 0.005 
0 1 3 22 .349 0.008 
0 1 4 24.47 0.02 
Mg 2+ 1 1 0 2.62 0.003 694 0.004 
Ca 2+ 1 1 0 2.64 0.02 240 0.005 
1 1-1 -8.53 0.04 
Mn 2+ 1 1 0 7.633 0.005 96 0.03 
Co 2+ 1 1 0 13.097 0.009 181 0.005 
1 1 1 17.27 0.01 
Ni 2+ 1 1 0 16.508 0.0034 279 0.002 
1 1 1 18.48 0.02 
Cu 2+ 1 1 0 19.16 0.01 400 0.0059 
1 1 1 21 .35 0.02 
1 1-1 8.24 0.02 
Zn 2+ 1 1 0 13.19 0.004 324 0.003 
1 1 1 16.720 0.02 
trien 0 1 1 9.880 0.0016 425 0.001 7 
0 1 2 19.065 0.0018 
0 1 3 25 .763 0.0025 












I L I M · I p 9 r I log P I a I n I R I 
Cu 2+ 1 1 0 20 .323 0.0091 406 0.0022 
1 1 1 23.437 0.008 
1 1-1 8.61 0.03 
ttda/trien Cu 2+ 1 1 0 21.15 0.03 437 0.0038 
1 1 1 24.75 0.02 
1 1 2 26 .81 0.04 
dtda/trien Cu 2+ 1 1 0 18.96 0.01 483 0.0026 
1 1 1 21.07 0.02 
4.4 .1 Protonation 
The stepwise protonation constants for ttda and dtda, with the exception of the last 
protonation step which occurs beyond the reliable range of the glass electrode, show a low 
standard deviation . The low R factor indicates the correctness of the protonation model. 
The experimental protonation curves are given in Figure 4.1 for ttda and in Figure 4.2 for 
dtda. The theoretical curves calculated using the constants given in the table are given on 
the clear sheet for comparison . The order of protonation was studied by n.m.r. under 
condition~ of varying pH , and is discussed in Section 5.4 . As triethylenetetramine (trien) was 
to be used as a competing ligand , its protonation constants for were also determined, and 
are given in Table 4 .1. W ith the exception of the minor 11-1 species , the agreement of the 
constants determined in this study with those in the literature is good. Literature values are 
given in Table 4.2 for comparison. 
Table 4.2 Formation constants for trien, at 25°C and ionic strength of 0.1 mol dm-3 . (Martell and 
Smith , 1989). 
I L I M I p qr I log P I 
trien H+ 0 1 1 9.74 
0 1 2 18.81 
0 1 3 25.40 
0 1 4 28 .67 
Cu2+ 1 1 0 20.05 
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For the three ligands p011 is similar, but decreases from trien to dtda. It is possible to 
rationalise these results in terms of protonation occurring at a central amine. The decrease 
in p011 can then be attributed to the inductive effect of the acetate groups, which is greatest 
for dtda where the acetate groups are in closer proximity to the central amine. The second 
protonation step of ttda and dtda is significantly weaker than trien, which is consistent with 
protonation at a terminal amine. In the case of the third protonation step p013 for ttda is 
somewhat lower than that for trien, but that for dtda is more than two log units lower as the 
last remaining nitrogen in the dtda chain is protonated . 
4.4.2 Copper 
ttda 
The formation and deprotonation curves of the Cu(ll)ttda system are shown in Figures 4.3 
and 4.4 . The pH range over which the data could be analysed is very narrow, and this is not 
an ideal situation as far as the computer analysis is concerned . 
As the complex was fully formed above pH 4, inclusion of data in this region in the modelling 
analysis d,id not result in a more acceptable model , and merely increased the error statistics . 
For this reason only the pH region 2-4 could be used to refine the betas. The formation 
curves are not superimposable , indicating that species other than simple mononuclear binary 
species are present. The curves rise towards a limiting value of 0.75, independent of 
component ratios and concentration, suggesting a complex stoichiometry of 1: 1 and a high 
proportion of protonated species. At the start of the titration (pH of approximately 2) , Q 
is approximately 2 indicating that complexation has already commenced. Within the data 
range analysed , Q did not rise above 3, and never reached then curve implying that the 
MLH species was still present at this point in the titration . The data collected over the full pH 
range of the titration , that is from 2 to 11 , was analysed. but the models chosen gave no 
significant improvement in the optimisation statistics and the high pH data was discarded. 
The very narrow effective titration range is a result of the high stability of the copper 
complexes relative to the pKa's of the ligands. Because of th is narrow pH range computer 
analysis of these data is not ideal. The study was, therefore. repeated using trien as a 
competing ligand. This enabled the titrations to be carried out over a much wider pH range. 
The results of these experiments are discussed later. The species distribution calculated 
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Species distribution curves for [Cu(ttda)] ; Total [Cu(ll)] = 1.6 mM =Total [ttda] 
The formation and deprotonation curves are shown in Figures 4.6 and 4. 7 for the dtda 
system . 
The formation curves are largely superimposable. indicating that only mononuclear binary 
species are present. The curves rise towards a limiting value of 1, independent of 
component ratios and concentration, suggesting a complex stoichiometry of 1: 1. At the start 
of the titration , at a pH of approximately 2, Q is > 1 indicating that complexation has 
already commenced. The n curve shows that at pH 3,6 there are essentially three protons 
to be displaced from the ligand while Q indicates that at this pH these protons have 
already been displaced by the metal ion. At higher pH values the n and Q curves are 
coincident indicating that no further complexation takes place. 
At pH > 1 O the Q curve rises above the n curve , which could indicate hydrolysis of the 
metal ion. A hydroxy species was refined in the computer optimisation , and this is also 
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symbols represent titrations with different concentrations (mM) and [ttda] :[Cu] ratios . 
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The species distribution calculated using the constants determined in this study is given in 
Figure 4.8. 
-:::::: 
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Figure 4.8 : Species distribution curves for [Cu(dtda)] ; Total [Cu(ll)] = 1.6 mM =Total [dtda] 
trien-ttda-dtda 
The formation curves at the different concentration ratios are moderately non-
superimposable , indicating that although mononuclear binary species predominate , other 
species are present. The curves rise towards a limiting value of 1, independent of 
component ratios and concentration , suggesting a complex stoichiometry of 1: 1. A p110 and 
p111 model was refined for this system , and this agrees well with literature results , both in 
terms of the model and formation constant values . Some literature values are given in Table 
4 .2 . 
The results of the ternary system Cu-dtda-trien are essentially in agreement with those 
obtained in the binary Cu-dtda system , and show improved statistics . Similar results were 
obtained for the Cu-ttda-trien system, although in this case the results for the binary system 
were somewhat better than the ternary system . 
Comparison of the results for the most predominant ML (metal-ligand) species of trien , ttda 
and dtda shows that the [Cu(ttda)] complex is the most stable , which is expected. The 
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increase in stability of the copper complex of ttda over that of trien must be due to the 
increased denticity of ttda. Comparison with trienda, Table 4.3 , shows that the [Cu(trienda)] 
complex is only marginally more stable than the [Cu(ttda)] complex even though the basicity 
of trienda is significantly higher than ttda . Within the complex, ring strain about the tertiary 
amines may account for this difference. It has been shown that in [Ni(edta)f (edta = 
ethylenediaminetetra-acetate) the ligand is quindentate, the sixth co-ordination site being 
occupied by a water molecule (Smith and Hoard, 1959). 
Table 4.3 Formation constants for [Cu(trienda)] (Chang and Douglas, 1981). 
I L I M I ~gr I log p I 
Trienda H+ 0 1 1 10.54 
0 1 2 20.40 
0 1 3 .· 27.10 
0 1 4 30.88 
Cu2+ 1 1 0 21 .78 
1 1 1 26.57 
The potentiometric results show that a significant amount of the protonated M(HL) species 
is formed at a low pH . For this species there is a relatively large difference in stability 
between trien and ttda [log K = 12.5 and 15.1 respectively for the equilibrium 
M + HL ...- MHL], and a much smaller difference between ttda and trienda (log K = 16.03) . 
These results could be accounted for by protonation occurring at a carboxylate site in the 
case of ttda and trienda. It would also support the hypothesis of ring strain about the tertiary 
amine of trienda being responsible for the decreased stability of the [Cu(trienda)] complex, 
as protonation would relieve this strain, making the [Cu(trienda)Hr complex more stable than 
the [Cu(ttda)Hr complex. The postulate that protonation of a carboxylate group occurs is 
also supported by the electronic spectra of the ttda complexes , and this is discussed in 
Section 5.2. 
4.4.3 . Zinc 
ttda 
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The formation curves are superimposable, indicating simple, stepwise, mononuclear 
complexation . The curves rise towards a limiting value of 1, independent of component 
ratios and concentration, suggesting a complex stoichiometry of 1: 1. The Q function is 
not as simple , indicating the presence of protonated species . This illustrates the 
complementary nature of the these two functions. The formation function is sensitive to the 
number of co-coordinate metal ions, while the deprotonation function is sensitive to the 
number of protons (or hydroxyl ions) in the complex. Within the data range analysed, Q did 
not rise above 3, and reached the n curve at a pH of 5. This implies that the MLH species 
was still present at this point in the titration . 
The species distribution calculated using the constants determined in this study is given in 
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Figure 4.11 : Species distribution curves for [Zn (ttda)];Total [Zn(ll)] = 1.6 mM =Total [ttda] 
The constants reported for the [Zn(trienda)] complex are given in Table 4.4, and are 















Table 4.4 · Formation constants for [Zn(trienda)] (Chang and Douglas , 1981 ). 
I L I M I egr I log P I 
trienda Zn2+ 1 1 0 19.13 
1 1 1 24.66 
1 1 2 28.01 
It is difficult to rationalise these discrepancies in terms of the structural differences between 
the ligands, especially as the protonation and copper(ll) complex formation constants of ttda 
and trienda are in much closer agreement. 
Inspection of the thermodynamic data (Martell and Smith , 197 4-1989) for zinc(ll) complexes 
of related ligands shows that the enthalpy factors make the biggest contribution towards the 
stability of the amino complexes . The neutralisation of the charge, and hence decrease in 
hydration is most likely responsible for the importance of entropy in determining the stability 
of acetate ligand complexes . The presence of two acetate groups on ethylenediammine (en) 
lowers llH0 for zinc(ll) complexation by about 4 kJ mo1·1 [ I:.H0 (en) = -29.3, 
llH0 (ethylenediammine-N,N'-diacetate) = -25.5 kJ mo1·1 ] , hence it is estimated that llH0 for 
zinc complexation of ttda to be of the order of -33.2 kJ mo1·1 [llH0 (triethylenetetrammine) = 
-37.2 kJ mo1·1 ] . Similarly llH0 for zinc complexation of dtda is estimated to be -23 .2 kJ mo1·1 
[llH0 (diethylenetriamine) = -27.2 kJ mo1·1 ] . At the same time the data show that llS0 
increases by about 30 J K-1 mo1·1 per acetate group. Hence llS0 is estimated to be about 
165 J K-1 mo1·1 for zinc(ll) complexes of ttda and dtda. This leads to values for llG 0 of -82.4 
and-72.4 kJ mo1·1 and equi librium constants of 10144 and 10127 at 25°C forthe formation of 
[Zn(ttda)] and [Zn(dtda)] respectively . This is in reasonable agreement with the values of 
15.65 and 13.19 obtained for p110 in this work. 
dtda 
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Figure 4.12: Experimental and calculated formation curves for the Zn(ll)dtda system. The 
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Figure 4.13: Experimental and calculated deprotonation curves for the Zn(ll) dtda system. The 













The formation curves are largely superimposable, indicating that only mononuclear binary 
species are present. The curves rise towards a limiting value of 1, independent of 
component ratios and concentration, suggesting a complex stoichiometry of 1: 1. At the start 
of the titration , at a pH of approximately 3, Q is zero indicating that as with nickel, zinc 
complexation commenced after the start of the titration. The ri curve shows that at pH 3,6 
there are essentially three protons to be displaced from the ligand while Q indicates that 
at this pH the displacement of these protons by the metal ion is beginning. As the titration 
continues the curves arising from different initial titration concentrations diverge, as the ratio 
of metal to displaceable proton varies. At higher pH values the ri and Q curves are 
coincident indicating that no further complexation takes place. 
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4.4.4 Nickel and Manganese 
ttda and dtda 
Inspection of the results of the potentiometric study of these system showed that there were 
many similarities in their behaviour under these conditions . The analysis of the results for 
these systems are therefore described together. 
The formation and deprotonation curves are shown in Figures 4.15 to 4.22 below. The 
speciation curves are given in Figures 4.23 to 4.26 (see appendix II) 
The formation curves are not entirely superimposable. This could indicate that species 
other than mononuclear complexes were present. The curves rise towards a limiting value 
of 1, at higher ligand to metal ratios and ligand concentration , but the 1: 1 ratio titrations 
begin to plateau at smaller values of z , suggesting a complex stoichiometry other than 
1: 1, but refinem ent of models including stoichiometries other than 1: 1 did not improve the 
optimisation statistics . It must be concluded that the data contains some error. The Q 
function indicates the presence of protonated species in most of the systems. In the 
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Figure 4.15: Experimental and calculated formation curves for the Ni(ll)ttda system. The symbols 
represent titrations with different concentrations (mM) and [ttda] :[Ni] ratios . 
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T 1.98: 1.99 e 1.97 : 1.99 ... 3.95: 1.99 + 3.94 : 1.99 
Figure 4.16: Experimental and calculated deprotonation curves for the Ni(ll)ttda system. The 
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Figure 4.17: Experimental and calculated formation curves for the Mn(ll)ttda system. The symbols 
represent titrations with different concentrations (mM) and [ttda]:[Mn] ratios . 
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Figure 4.18: Experimental and calculated deprotonation curves for the Mn(l l)ttda system. The 
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Figure 4.19: Experimental and calculated formation curves for the Ni(ll)dtda system. The symbols 
represent titrations with different concentrations (mM) and [dtda] :[Ni] ratios. 
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Figure 4.20: Experimental and calculated deprotonation curves for the Ni(ll)dtda system. The 
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Figure 4.21 : Experimental and calculated formation curves for the Mn(ll)dtda system. The 
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Figure 4.22: Experimental and calculated deprotonation curves for the Mn(ll) dtda system. The 














The formation and deprotonation curves are shown in Figures 4.27 and 4.28 for this system. 
The formation curves are largely superimposable, indicating that only mononuclear binary 
species are present. The curves rise towards a limiting value of approximately 0.9, and 
curves representing different component ratios and con~entration begin to diverge at 
approximately Z = 0.6, suggesting a complex stoichiometry other than 1: 1. The levell ing 
off of the formation curve at a value less than 1 could also indicate the presence of 
precipitate (Smith , Motekaitis, and Martell, 1985). During the titration of these solutions no 
precipitate was observed, but the solution changed colour. As oxidation to Co(lll) was 
considered to be a possibility, the reaction mixture was back titrated to check that the system 
was reversible . The colour change was not reversibl~. and the data was not superimposable 
with the forward titration . The conclusion drawn was that at higher pH the deviation from the 
expected curve was due either to the formation of a very fine precipitate , or to oxidation of 
the cobalt (II) to cobalt(lll). Data from the non superimposable region was not included in 
the data analysis . There is good agreement between the experimental Z plot and the 
theoretical pseudoplot, indicating that the model and betas are essentially correct. At the 
start of the titration, at a pH of approximately 2, z is zero, and begins to increase at a pH 
of approximately 3,3, indicating the commencement of complexation . The n curve shows 
that at pH 4 there are essentially three protons to be displaced from the ligand while 
indicates that at this pH just over two of these protons have been displaced by the metal ion. 
The agreement between the experimental and theoretical plots is good. 
The speciation curves , Figure 4.29, show that the formation of the ML complex begins at pH 
3, and by pH 5 it is the only complex of significance in the solution. The degree of formation 
of the MLH complex is low, explaining the relatively high standard deviation of the p 
calculated for this complex. Due to the low percentage formation , the question must be 
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Figure 4.27: Experimental and calculated formation curves for the Co(ll)ttda system. The symbols 
represent titrations with different concentrations (mM) and [ttda] :[Co] ratios. 
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Figure 4.28: Experimental and calculated deprotonation curves for the Co(ll) ttda system. The 
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Figure 4.29: Speciation curves for the system [Co(ttda)] ; Total [Co(ll)] = 1.6 mM =Total [ttda] 
dtda 
The formation and deprotonation curves are shown in Figures 4.30 and 4.31 for this system. 
The formation curves are largely superimposable , indicating that mainly mononuclear binary 
species are present. The curves rise towards a limiting value of approximately 0.8, as is the 
case with the Co-ttda system, suggesting the possibility of precipitation or oxidation in the 
vessel. At the start of the titration, at a pH of approximately 2.3, Z is zero indicating that 
complexation commenced after the start of the titration . Complexation begins at a pH of 
approximately 3.4 , at which point the ri curve shows that there are essentially three protons 
to be displaced from the ligand . As the pH increases during the titration the n and Q 
curves approach each other, but never become coincident , indicating that under the 
conditions of these titrations complexation is never complete . 
The species distribution calculated using the constants determined in this study is given in 
Figure 4.32 (see Appendix II ). 
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The values for the formation constants obtained for these ligands were compared with 
literature values (Martell and Smith, 197 4-1989) for similar compounds . These values are 
given in Table 4.5 below. 
Table 4.5: Formation constants for compounds similar to dtda 
I 4 co-ordinate I p I 5 co-ordinate . I p I 
4 N (trien) 10,9 5 N (tetren) 13,3 
2 N 2 0 (edda) 11 ,2 3 N 2 0 (dtda) "13, 1 
The values obtained for the ligands containing only nitrogen donor ligands are similar to 
those obtained for the mixed donor ligand. It appears from these results that for the cobalt-
nitrogen or cobalt-oxygen systems the donor atom has little influence on the stability of the 
complex. 
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Figure 4.30: Experimental and calculated formation curves for the Co(ll)dtda system. The 
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Figure 4.31: Experimental and calculated deprotonation curves for the Co(ll)dtda system. The 












4.4.6. Calcium and Magnesium 
ttda 
The formation curves are given in Figure 4.33 and the deprotonation curves in Figure 4.34 
for calcium , and in Figures 4.35 and 4.36 for magnesium. 
The formation curves for the Ca-ttda system are superimposable , indicating that the major 
species formed are simple mononuclear complexes. At high pH the formation curves fan 
back, which is characteristic of hydroxy species formation . This is shown more clearly by the 
deprotonation function . Computer analysis of the data confirms the presence of only two 
species, ML and MLH_1 . The 'goodness of fit' between the experimental data and the 
proposed model is indicated by the superimposability of the curves in the Figures on the 
clear page. 
dtda 
The formation curves are given in Figure 4.37 and the deprotonation curves in Figure 4.38 
for calcium, and in Figures 4.39 and 4.40 for magnesium. 
The results obtained are similar to those for the Ca-ttda system . The ML complex is the 
major complex formed under these conditions , with the calculated formation constant 
marginally lower than that obtained for the Ca-ttda. This must be due to the higher denticity 
of the tetramine ligand. 
A comparison of the results obtained for the calcium(ll) and magnesium(ll) systems is 
interesting. The [Mg(dtda)) complex is more stable than the [Mg(ttda)] complex. Presumably 
this is due to the small size of the magnesium(ll) ion. For the larger calcium(ll) ion the 
expected order of complex stabil ity [Ca(ttda)] > [Ca(dtda)) is seen. 
Ionic radius is a common theme running through the co-ordination chemistry of calcium(ll) 
and magnesium(ll) (Burgess , 197 4) . The higher charge density of the magnesium(ll ) ion 
tends to make complexes of this metal ion more stable than the corresponding calcium(ll) 
complexes . On the other hand, the small size of the magnesium ion makes multidentate co-
ordination difficult. The results of this study are consistent with these observations . The 
[Ca(dtda)] complex has the same stability as the [Mg(dtda)] , while the [Ca (ttda)] complex 
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Figure 4.33: Experimental and calculated formation curves for the Ca(ll)ttda system. The symbols 
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Figure 4.34: Experimental and calculated deprotonation curves for the Ca(ll)ttda system. The 




















• 8.21 T 7.78 • 7.24 A 13.45 + 12.45 83 6.28 X 12.29 
Figure 4.35: Experimental and calculated formation curves for the Mg(ll)ttda system. The symbols 
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Figure 4.36 : Experimental and calculated deprotonation curves for the Mg(ll)ttda system. The 
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Figure 4.37: Experimental and calculated formation curves for the Ca(ll)dtda system . The 
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Figure 4.38: Experimental and calculated deprotonation curves for the Ca(ll)dtda system . The 

























.. 8.49 • 8.52 • 8.8 + 7.96 
x 8.46 181 11 .78 x 9.03 :& 15.24 
4 
Figure 4.39: Experimental and calculated formation curves for the Mg(ll)dtda system. The 
symbols represent titrations with different dtda concentrations . [Mg] = 0 - 32 (mM). 
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Figure 4.40: Experimental and calculated deprotonation curves for the Mg(ll)dtda system. The 












The species distribution curves for these systems are given in Figures 4.41 and 4.42 for 
calcium and in Figures 4.43 and 4.44 for magnesium (see appendix II) . 
4.5 Discussion 
The order of stability of the first row trans ition metal complexes of both ttda and dtda follows 
the Irving-Williams series (Irving and Williams , 1948; 1953). This order is demonstrated 
graphically in Figure 4.45, where p1 10 is plotted against the metal. 
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Figure 4.45: Increase in p11 0 for complexes of ttda , dtda , edda, trien and tetren with atomic 
number of divalent first row transition metal ions. 
In all cases , the p110 stabil ity constants measured for the ttda complexes are larger than 
those determined fo r dtda. Th is is due to the increased stability afforded by the formation 
of 5 chelate rings for ttda in comparison to the 4 formed by dtda and can be explained due 












The direct comparison of tetren, a five donor site ligand with only nitrogen donor atoms, with 
dtda, which also has five donor atoms, three nitrogen and 2 oxygen, shows a high relative 
stability for dtda for the Mn+2 complex, while from Co+2 onwards the tetren complexes are 
increasingly more stable. This can be accounted for in terms of the hard and soft acid and 
bases concept, as the divalent metal ions become increasingly 'soft' from manganese to 
copper. The same trend is seen of the four donor analogues, trien and edda . 
The final point of note is that for trien and tetren there is a large relative increase in the 
stabilities of the copper complexes compared to those of the complexes with the other 
metals. This increase is not seen with either ttda or dtda. This is probably due to the 














The experimental procedures used are similar to those used by other workers in this field. 
In essence, solutions containing differing metal and ligand concentrations and ratios were 
titrated potentiometrically with strong acid or base. The ionic strength of the solutions was 
kept as constant as possible by the addition of an inert background electrolyte (0.15M NaCl). 
The resulting data, (ml , mV), was then analysed using the ESTA suite of programmes 
(Murray and May, 1984) to obtain the "best " set of stability c_onstants. The resulting model , 
or models , were used to generate theoretical formation curves which could be compared 
with the experimental curves . The extent of the agreement between the experimental and 
theoretical curves , together with the optimisation statistics were used to assess the valid ity 
of the proposed model. Protonation constants were obtained by excluding the meta l ions 
from the titrand solution . 
The chemicals used are given in Table 4.6. These were used without further purification , 
except where indicated. 
Table 4.6: Chemicals used in the potentiometric work 
I Chemical I Source I Purity I Purification Method I 
Zinc metal Merck G.R. 
edta NT Lab Supplies AR 
Potassium hydrogen Merck GR Recrystall ised 
phthalate 
NaCl Saarchem Ltd AR 
HCI Merck Titrisol ampule 
MgCl2.6H20 Merck GR 
CaCl2.4H20 Merck GR 
MnCl2.4H20 Merck GR 
CoCl2.6H20 Merck GR 
NiCl2.6H20 Merck GR 
CuCl2.2H20 Merck GR 
, 
ZnCl2 Merck GR 














Chemical I Source I Puritl': I Purification Method 
Merck Technical, Distillation under vacuum, 
70% followed by fractional 
crystallisation of the 
hydrochloride. Recrystallised 
from dilute ethanol (Sacconi , 
Paolletti , and Ciampolini, 1961) 
Standard zinc solutions were prepared in a calibrated volumetric flask by dissolving zinc 
metal in concentrated hydrochloric acid and diluting the solution to volume. Temperature 
corrections were made when calculating the resulting concentration(CRC Handbook of 
Chemistry and Physics, 1983). 
Edta solutions of the required concentrations were prepared and standardised against the 
appropriate zinc standard solution (Vogel, page 317.) . 
Metal chloride solutions were prepared as required . Sufficient sodium chloride was added 
to give a final ionic strength of 0.15M. The solutions were standardised against edta (Vogel , 
324-325) . 
Sodium hydroxide solutions (0 .1 M) were prepared under a nitrogen atmosphere from Merck 
titrisol standard ampules . Sodium chloride was added to give a final ionic strength of 0.15M. 
The solutions were standardised against Potassium hydrogen phthalate using the method 
of Gran (Gran, 1952). 
Hydrochloric acid solutions (0.1 M and 0.01 M) for titration and electrode calibration were 
prepared from titrisol ampules and dilution of the bulk solution, respectively . Both solutions 
were adjusted for ionic strength with sodium chloride and were standardised against sodium 
hydroxide and borax (Vogel , 320). 
With the exception of the 0.01 M HCI solution, which was used only for electrode storage and 
calibration , all solutions were maintain~d under an atmosphere of purified nitrogen. All the 
solutions were prepared using double glass distilled deionised water which had been freshly 
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The Titrations were carried out in a double walled titration vessel (Metrohm, cat. No. 
6.1405.0001) thermostated at 25.0 ±0.1°C, under an inert atmosphere of nitrogen. The high 
purity nitrogen was first passed through 4 thermostated wash bottles containing 50% KOH 
solution , 15 g pyrogallol in 100 ml 30% KOH solution , distilled water and 0.15M sodium 
chloride , respectively . A gas bubbler was attached to the gas outlet from the titration vessel 
to prevent back diffusion . 
The reaction between each of the ligands and the divalent metal ions of calcium, cobalt, 
nickel copper and zinc was studied using the following experimental procedure. Sufficient 
ligand to give an initial concentration between 1.5 and 3.4 mM was weighed out into the 
titration vessel. An appropriate mass of sodium chloride was added to give an initial ionic 
strength of 0.15M in 20 ml. The vessel was then attached to the titration apparatus and 
flushed well with nitrogen. The ligand and salt were then dissolved in 20 ml degassed, 
distilled water. Concentrations are expressed using the molar scale, ignoring molar partial 
volumes which are negligible . The pH of the solutions was immediately adjusted to 
approximately 11 by the addition of sodium hydroxide. The need for this precaution is 
explained in section 3.2. If metal ions were to be included in the titration , 20 ml of the metal 
solution was added as well . The solution temperature was stabilised at 25 °C, and then 
titrated with 0.1 M hydrochloric acid . All solutions were introduced via piston burettes 
(Metrohm , cat no. 6.1521 .220) , read to a precision of 0.01 ml. All titrations were performed 
in duplicate. The solution was stirred magnetically. 
Analysis of the data obtained with the above method showed that the copper interaction with 
the ligands was very powerful , with , in the case of ttda , the complex being 50% formed even 
at pH 2. For this reason the reaction was also studied using a competitive ligand, after the 
method of Martell et al (Harris and Martell , 1976). Trien was chosen as the competing ligand 
as its complexation equilibria with copper are well documented in the literature, and it is 
unlikely to form ternary complexes with ttda or dtda. 
The above procedure was followed, with solid trien HCI being weighed into the titration 
vessel. Sodium chloride was again added to achieve an ionic strength of 0.15M in 20 ml of 
solution . The protonation and copper formation constants were determined in separate 
experiments using the same procedure. 
When the divalent manganese solution was added to the alkaline ligand solution a brown 
precipita te , presumably manganese hydroxide , formed , and the titration procedure was 
modified to avoid this . The pH of the solution was raised to approximately 4, instead of 11 , 
and then titrated with base until a precipitate was observed. 
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As the binding between the ligands and magnesium was very weak, it was not possible to 
obtain usable data for these systems, even using high concentrations of the ligand and 
metal. An upper limit for the possible reactant concentration is imposed by the requirement 
for constant ionic strength . If the reactant concentrations are too high, their contribution to 
the total ionic strength of the solution cannot be considered as negligible. In order to 
overcome this , the reaction solution was adjusted to a pH of approximately 4, and titrated 
with base to a preselected pH , somewhere between 8.5 and 10.5. The solution was then 
titrated with a 0.5M solution of Magnesium chloride. Using a large number of titrations it was 
possible to cover a sufficiently large pH range, and obtain high ligand to metal concentration 
ratios (Linder, Torrington , and Seeman, 1983). 
In all experiments the reaction was followed using a glass electrode sensitive to hydrogen 
ion (Metrohm, cat.no. 6.0102.000) coupled to a calomel reference electrode (Metrohm, 
cat.no. 6.0702 .000) with a renewable liquid junction. The emf readings were taken on a 
Radiometer PHM 84 digital pH meter, which was read to a precision of 0.1 mV. The titrations 
were microprocessor controlled using software developed in these laboratories. 
The ionisation constant for water, pf<w, was determined from strong acid-strong base 
titrations , using the computer programme MAGEC (Williams, May, Linder and Torrington, 
1982). A value of -13.76 was obtained and used throughout. Table 4.7 gives literature 
values determined under similar conditions. 
Table 4.7: Literature pf<w values, determined at 25.0°C 





0.4 NaCl Dynssen and Hansoon , 1972 
0.14 KN03 Jameson and Wilson , 1972 
0.1 NaCl Teder, 1972 
0.1 NaCl Whitfield, 1972 
The electrode was calibrated using the protonation data after the method of W illiams et al 
(Williams, May, Linder and Torrington , 1982). A strong acid reading in 0.01 M HCI was 
correlated to the E0 value obtained. A strong acid read ing was taken before and after each 
titration and the mean of these readings used to cal ibrate the electrode for the metal 
titrations. 
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The use of ECCLES, the computer blood model, to design ligands which would selectively 
mobilise copper in plasma, and the determination of the formation constants of the target 
ligands with some of the important metal ions present in blood, suggested that the two 
ligands, ttda and dtda, had the potential to be effective anti-inflammatory agents when 
combined with copper. The simulation results indicated that the complexes survived the 
coord inating medium of plasma. This , we believe, is a necessary condition for activity, but 
is not a sufficient condition . There are other properties of the complexes which are also 
important for biological activity . These properties include the lipophilicity, biodistribution , 
pharmokinetics , and superoxide dismutase activity . The ultimate test, however, is animal 
screens of anti-inflammatory activity 
The solution structure of the complexes will have an effect on the ir behaviour in biofluids. 
The rapid transport of the complex through cell membranes will be determined by its 
lipophilicity. The ligands considered were all di-anionic, to neutralise the charge on the 
divalent copper ion . The degree of bonding of the carboxylic residues is therefore of 
interest. A situation where the carboxylates are loosely associated will give rise to a larger 
hydration . sphere, and th is will reduce the lipophilic nature of the complex. 
Several theories exist as to the mode of action of the copper in reducing the inflammation 
associated with rheumatoid arth ri tis. Some investigation into the performance of the copper 
compl ex in models used to assess the biolog ical potentia l of the anti-inflammatory agents 
was of interest in th is work . These investigations included an assay of superoxide 
























Studies of the electronic spectra of complexes often allow structural aspects of the 
complexes to be determined (Nicholls, 197 4) . Of particular interest in this study are the 
ligand field spectra , which arise from transitions between non-degenerate metal d-orbitals 
caused by the low symmetry of the complexes. The octahedral complexes formed by 
copper (II) ions are generally tetragonally distorted. The degree of distortion is determined 
by the strength of the bonding and the structure of the complex. In a multi component 
system, by changing the conditions of the solution , it is possible to change the equilibrium 
concentration of the individual species. This provides a tool to examine changes in the 
structure of the predominant complex, as the UV spectrum will change as the relative 
concentrations of the species present change. 
5.2.2 Theory 
In complexes of first row transition metal ions the degeneracy of the metal d orbitals is lost 
as a result of the presence of the ligands. The influence of the ligands on the metal orbitals 
varies due to the symmetry of the complex, and separates the d orbitals into a set of two e
9 
orbitals and a set of three t29 orbitals. As the t29 orbitals have their lobes pointing between 
the axes , and the e9 orbitals point along the axes , in octahedral complexes the e9 orbitals 
are at higher energy than the t29 orbitals. 
When more than one valence electron is present, coupling occurs between the quantum 
numbers for the individual electrons. For elements up to an atomic number of 30 the 
Russell-Saunders coupling scheme applies, and in this scheme it is assumed that spin-spin 
coupling > orbit-orbit coupling > spin-orbit coupling . In spin-orbit coupling the spin and 
orbital angular momenta on the same electron are concerned. 
The information concerning the resultant energy levels is conveyed by means of the Term 
Symbol 
Term symbol= '2s +1lLJ 
S is the spin-spin coupl ing quantum number 
L is the orbit-orbit coupling quantum number 
J is the spin-orbit coupling quantum number 












For each of the d1 to d9 ions the allowed terms can be derived. In the case of the copper (II) 
ion , there is only a 20 term. 
Under the quantum-mechanical selection rules for light absorption , given below, d-d 
transitions are forbidden . 
1 Spin forbidden : transitions in which there is a change in the number of unpaired 
electrons are forbidden . 
2 Orbitally forbidden (Laporte rule): Transitions involving the redistribution of electrons 
in a single quantum shell are forbidden . Transitions of the type g-+g and u-+ u are 
partially forbidden . 
The spin forbidden rule is relaxed by spin-orbit coupling, but the absorptions are weak. 
If complexes have a centre of symmetry, the Laporte rule can be relaxed by a vibronic 
mechanism. For complexes that already lack a centre of symmetry, mixing of p and d 
orbitals allows transitions between orbitals of varying amounts of p character. 
In complexes the free ion terms give rise to crystal-field terms. For the d9 ions these terms 
are E
9 
and T29 terms , with the E9 term being the ground state. Thus for octahedral copper 
(II) complexes a single 2 E
9 
- • 
2 T29 transition is expected . Jahn-Teller distortion generally 
leads to broadening of the spectra . 
For electronic absorption spectra of solutions containing more than one absorbing species 
the Beer-Lambert law can be expanded to give a linear combination of terms for each 
individual species , Equation 5.2.1 
where 
AA = Absorption at wavelength >.. 
E; = molar adsorption coefficient at wavelength>.. of the i th species 
(dm3 mo1·1cm·1) 
c; = concentration at wavelength >.. of the i th species (mol dm-3) 













5.2.3 Results and discussion 
To examine the solution structure of the copper-ttda complex, the UV/visible spectrum of the 
complex was recorded as a function of pH . The variation in £ max. with pH is given in 
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Figure 5.2.1: Variation in Emax with pH for the Cu-ttda system. [Cu]= [ttda] = 1.6 mmol dm-3 
For regular octahedral copper(ll) complexes the separation of the T29-E9 orbitals is about 770 
nm for Cu06 and about 550 nm for CuN6 (Lever, 1985). With tetragonal distortion , as the 
axial bond lengthens the in-plane ligands move in and the absorption band shifts to shorter 
wavelength , for example for [Cu(trien)(H20)2]
2
+, '-max = 575 nm (Hedwig , Love and Powell , 
1970). Constraint of the axial bond by being part of a chelate ligand results in a shift to 
longer wavelength . In the case of [Cu(ttda)] , a '-max of 624 nm is consistent with equatorial 
co-ordination of the four amine groups and axial co-ordination of the two carboxylate groups. 
Above pH 4, where according to the potentiometric results only the ML species is present, 












pH 4, however, £max increases and then decreases as the entire complex dissociates. The 
increase in Emax. corresponds to the formation of the M(HL) species, which distorts the 
structure from regular octahedral and the selection rules are relaxed . This same variation 
in Emax is shown by [Cu(NH3)n(H20)6_n]
2
+ as n is varied. There is no change in >-max. For 
[Cu(trien)]2+ >-max. shifts from 575 to 610 nm upon protonation of a co-ord inated amino group 
(Sacconi, Paoletti , and Ciampol ini , 1961 ). The change in Emax. and the lack of change in >-max. 
can be explained by protonation occurring at one of the carboxylate sites. Release of one 
axially coordinated carboxylate groups from the metal ion increases the tetragonal distortion 
of the complex resulting in an increase in the absorption coefficient. For the ML species Emax 
= 110 while for the M(H L) complex Emax = 176 cm3mo1-1 cm-1. 
5.2.4 Experimental 
The solutions used in this section were similar to those used in the potentiometric 
determinations of the formation constants. 
The test solution was prepared by dissolving 0.0635 grams of ttda and 0.3822 grams of 
NaCl in a 50 ml volumetric flask. To this was added 5 ml of a 0.01588 M copper chloride 
solution. Sufficient NaOH was added to the solution to give a pH of approximately 10 once 
the solution had been made up to the mark. These quantities gave final concentrations of 
0.001588 M with respect to copper, 0.0032 M with respect to ttda. The ionic strength was 
0.15 M with respect to NaCl. 
The spectra were recorded on a Philips PU 8700 spectrophotometer. A 0.001588 M copper 
chloride solution made up in 0.1 5 M NaCl was used as the blank. 
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As outlined in Chapter 1, there is evidence which suggests that superoxide and other free 
radicles released into the synovial cavity are linked to the inflammatory process and tissue 
degradation. Suppression of radical production and/or rapid destruction of free radica ls 
is therefore important in tissue protection. Superoxide dismutases, which are 
metalloproteins containing copper-zinc, manganese or iron , occur naturally in synovial fluid . 
These proteins are responsible for the destruction of superoxide in vivo. It has been 
suggested that the anti-inflammatory activity of copper complexes is related to their abili ty 
to destroy superoxide. For this reason the superoxide dismutase activity of the copper 
complex of ttda was tested using the method of Roberts and Robertson (Roberts and 
Robinson, 1985). 
5.3.2 Theory 
In the Roberts and Robinson procedure, superoxide radicals are produced by the reaction 
of hypoxanthine with xanthine oxidase, and detected by the reduction of nitrobluetetrazolium 
(NBT) to a blue formazan . Superoxide like activity is detected by the inhibition of the NBT 
reduction. Edta, is used as a competing ligand, to approximate the presence of albumen 
in blood. It's copper complex has no SOD-like activity (Lengfelder and Weser, 1981). The 
SOD activity of a complex is quoted as the concentration or the complex, with respect to 
copper, which will inhibit NBT red uction by 50% (1 50) . 
The activity of the complexes determined in this test falls into one of three categories . 
Those complexes with SOD like activity which are stable in the presence of edta , those 
which are active but are less stable than the edta complex, and those which do not inhibit 
NBT reduction . 
Inhibition of NBT reduction is calculated from the optical densities at 550 nm as fol lows. 
Inhibition = 1 -
test - testblank 
100%control- controlblank 
Where 
Test = The assay with the test ligand 
Test blank = Assay wi th the test ligand but without xanthine oxidase 
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· 100% control = Assay excluding both copper and test ligand in the presence of 
xanthine oxidase. 
Control blank: = Assay excluding both copper and test ligand in the absence of 
xanthine oxidase 
5.3.3 Results 
Several assays were carried out in parallel. Cu(gly}i was used to check the weak chelator 
response; the control and blank assays; and the test ligand . 
The results of the assay for the ttda copper complex are displayed graphically in 
Figure 5.3.1. The results indicate that there is no significant catalyses of the dismutation of 
the superoxide radical by th is complex. A single point assay was repeated for the copper 
complexes of dtda and ttda and these are also given in Figure 5.3.1. In both cases the per 
cent inhibition was only 4%. 
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Figure 5.3.1: SOD activity of Cu(ttda) , as a function of copper concentration , and a single 












From these results it is apparent that these complexes do not catalyse the dismutation of 
the superoxide radical. 
An assay run with glycine gave an 150 of approximately 20µ M, which is similar to the results 
reported by Roberts et al (Roberts and Robinson , 1985). 
5.3.4 Experimental 
Bulk solutions of copper glycinate (9,74 x 10-3M Cu+2 , 2,09 x 10-2 M glycine) , ttda 
(5, 1 x 1 o-3M) and edta {1 ,2 x 1 o-3M) were made up in 1 OOmM Hepes buffer. Bulk solutions 
of hypoxanthin and NBT were made up. Copper/glycine/ttda bulk test solutions were made 
up by combin ing 0,25 ml of the bulk copper/glycine solution and 1 ml of the bulk ttda solution 
and diluting to 25 ml with Hepes buffer (9.7 x 10-5 M cu+2) . Aliquots of this solution were 
diluted with Hepes buffer to give the required copper_-ttda complex concentration . To these 
solutions , the required amounts of hypoxanthine and NBT were added to provide a final 
concentration of 20µ M hypoxanthine and 500µ M NBT in 4 ml of assay solution. The test 
solutions were incubated at 20°C in the dark, and the reduced NBT was measured at 550 
























N.m.r. is an important tool in the investigation of chemical structures and reaction 
mechanisms and has been extended to whole body imaging in medical diagnosis. The use 
of this technique in chemistry was initially restricted to study of the proton , but developments 
in instrumentation and procedures have resulted in the routine study of nuclei with spin other 
than Yi and with low abundance. 
In this work we have used n.m.r. to determine the sequence of protonation of ttda and dtda 
(Letkeman, 1979), and to investigate the solution structures of the calcium and zinc 
complexes (Hague and Moreton, 1987). In both protonation and complexation reactions the 
presence of the proton or metal shifts the n.m.r. signal arising from the protons attached to 
the neighbouring carbons . The nature of the bonding and the degree of complexation both 
influence the resulting signal. The chemical shifts of the 1 H and 13C spectra were analysed 
by plotting the shift against the pD (or Ca concentration). Rapid changes in the chemical 
shift indicate complexation at the nitrogen closest to the proton concerned . From the data 
the value of the equilibrium constant can also be calculated . 
5.4.1 Theory 
The general theory of n.m.r. is well known and is dealt with in many standard texts (for 
example Akitt, 1983). As the main use of n.m.r. in this work was to study the change in 
chemical shift on complexation of the ligand with either protons or meta l ions, the basic 
theory was applied . However, it is also possible to determine formation constants from 
n.m.r. data, and the theory for this is given below (Hague, and Moreton, 1987). 
Assuming rapid exchange between the various species present in solution , the observed 
chemical shift for a particular atom is the average of the chemical shifts of that atom in the 
various species (Ci; ), weighted according to their fractional populations (p;) : 
Thus for ttda , which can exist in un-protonated up to hexa-protonated fo rms (L, HL, up to 












The fractional populations are also related through the acid dissociation constants. 
Addition of an appropriate concentration of a metal ion to the solution will result in a change 
in the chemical shift if complexation takes place. The chemical shift at a particular pH is 
given by 
where the first term on the right is a composite one containing all the contributions from the 
uncomplexed ligand and the second represents the contributions from the various 
complexes. 
5.4.2 Results and discussion 
5.4.2.1 Protonation 
The structures for ttda and dtda are given in Figure 5.4.1, to indicate the labelling of the 
proton and carbon sites used in the discussion below. 
1 14 
HOOC 2 4 s 1 s 10 11 13 COOH 
~~~~ r-
N N N N 
ttda 
11 
HOOC 2 4 s 7 s 10 COOH 
~~~~ 
N N N 
dtda 
Figure 5.4.1: Structures of ttda and dtda giving the numbering of the carbon atoms. 
. · . :·. 
The order of protonation of ttda and dtda were determined by measuring the 1 H and 13C 
n.m.r. as a function of pD. 
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The variation of the chemical shift of ttda with changing pD for 1 H is given in Figure 5.4.3, 
and for dtda in Figure 5.4.4 . 
0 2 4 6 8 10 12 
pD 
Protons attached to 
Figure 5.4.3: pD Dependence of the 1H n.m.r. chemical shifts for ttda 
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With the addition of the first proton to ttda, all 1 H resonances are shifted to higher o, that is 
they are all shielded, and hence protonation must be occurring to the same degree at all four 
nitrogen sites . The second step is clearly at N1(N4) with the third proton N4(N 1) . The signals 
for the protons attached to C4 ,C11 and C5 , C10 exhibit a complex fine structure that is 
consistent with an A282 system, and the signal arising from the protons attached to carbon 
atoms C2,C13 moves upfield to approximately the same extent. The signal arising from the 
protons attached to carbon atoms C7,C8 show no fine structure throughout the change in pD, 
and relative to the other protons, a small change in chemical shift. The addition of the fourth 
proton at pD 4 has the greatest influence on the C7,C8 protons , indicating the protonation 
is at the central nitrogens. The re latively rapid shift in the resonance of the C2,C13 protons 
below pD 3 is consistent with addition at the acetate sites. This protonation scheme is given 










Figure 5.4.5: Protonation scheme for ttda . 












By analogy, the protonation sequence for dtda is at all three nitrogen sites on addition of the 
first proton , at the terminal nitrogens for the second and at the central nitrogen for the th ird. 
Subsequent protonation occurs at the acetate residues. 
Assignment of the 13C spectra of ttda followed from the assignment of the 1H n.m.r. spectra 
(Jackson and Kelly , 1989) ·via a two-d imensional heteronuclear corre lation (H ETCOR) 
experiment (Bax, 1983), Figure 5.4 .6 This showed that the 13C chemical shifts were not in 
the same order as the 1H chemical shifts, Ci being shifted to lower field . 
0 
Figure 5.4 .6: N.m.r. spectrum of ttda at pD 6.0 obtained using the HETCOR pulse sequence with 












5.4.2.2 Ca-ttda and Ca-dtda 
'O 
The 13C chemical shifts of the Ca-dtda system as a function of pD for are shown in Figure 
5.4.8. Over the entire pD range only single resonances are observed for non-equivalent 
carbon atoms, indicating that the ligand is in rapid exchange between the various possible 
isomers. Both the 1H, Figure 5.4.9, and 13C n.m.r. titration curves level off at pD 10 
indicating that the formation of the [Ca(dtda)] complex is complete. This is reflected in the 
species distribution diagram of this system, Figure 4.42 (see appendix II). However, beyond 
pD 10 the potentiometric study indicated that substantial formation of the [Ca(dtda)(OH)]" 
complex occurs . This is not reflected in the n.m.r. titration curve, presumably because the 
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Figure 5.4.8. pD Dependence of the 13C n.m.r. chemical shifts of dtda in the presence of 
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Figure 5.4.9. pD Dependence of the 1H n.m.r. chemical shifts of dtda in the presence of 












The variation in 13C n.m.r. chemical shift of ttda as a function of calcium concentration is 
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In both systems the curves reach a plateau after the addition of one equivalent of metal ion . 
This indicates that complexation is complete after this addition. The addition of excess 
metal does not result in further complexation. Using the method given in Section 5.2, it is 
possible to analyse the titration curve for the stability of the complexes formed . Values of 
1022 and 1032 were obtained for ~11 0 of dtda and ttda respectively . Considering the variation 
of ionic strength between this system and that used for the potentiometry, this value agrees 
well with that determined in the potentiometry study. From the figure it can be seen that the 
chemical shift of cs is insensitive to complexation , as was the chemical shift of C7 of ttda , 
suggesting that the central nitrogens are not involved in complexation . A careful 
examination of the n.m.r. titration curves revealed a crossover of the C4 and cs resonances 
of dtda and the C7 , C4, and C5 resonances of ttda. A similar crossover is seen in the 
chemical shifts of 3,7-diazanonane-1,9-diamine.(Dougal, Hague and Moreton, 1987). 
5.4.2 .3 Zn-ttda 
The study of the solution structure of the [Zn(ttda)] was complicated by the formation of 
several isomers in solution, and by the line broadening associated with exchange between 
these isomers. While a complete assignment of the spectra could not be made, conclusions 
about several aspects of the structure of the [Zn(ttda)] and [Zn(Httda)t complexes in 
solution could be drawn. 
At low pD, signals attributable to the free ligand can be seen. These are marked as such 
in Figure 5.4.12. 
Two very broad signals are seen for H2 and H4 , Hs, H7 . This spectrum is typical of 
protonated polyaminopolycarboxylate complexes , with protonation at the terminal nitrogen 
(Letkeman and Westmore, 1971 ). Since separate signals are seen for both the free and 
complexed ttda, exchange between these two forms must be slow on the n.m.r. time scale 
As the pD is raised the 1H n.m.r. signals move to higher field and gain fine structure . The 
major spectral changes occur between pD 3 and 5 which corresponds to the 
potentiometrically measured pKa for the [Zn(Httda)t complex of 3.5. At pD 8 the [Zn(ttda)] 
complex is completely formed . At this pD the signals arising from the acetate groups (H2) 
consist of several broad peaks and a number of AB quartets (JA8 = 7 Hz) . The non-
equivalence of these geminal protons and hence the AB pattern is a clear indication that 
the acetate group is co-ordinated to the metal and that exchange of these acetate groups 












of H4 ·and H5 , together with the slow interconversion between different geometric isomers, 
results in the broad signals seen between o 2.4 and 3.2. The existence of several geometric 
isomers in solution is confirmed by the 13C n.m.r. spectrum. Here again signals attributable 
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Figure 5.4 .12. Proton n.m.r. spectra of Zn-ttda as a funct ion of pD. [ttda] =[Zn]= 0.1 mol dm·3 . 
Starred peaks are assigned to free ligand. 
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Figure 5.4 .13. Carbon-13 n.m.r. spectrum of Zn-ttda. [ttda] =[Zn]= 0.1 mol dm·" . Starred peaks are 













For the pD scans of the ligands ttda and dtda solutions of appropriate concentration to give 
reasonable spectra were prepared. No attempt was made to use any specific concentration . 
For the calcium/ttda scans an approximately 0.2 mol dm-3 solution of ttda was prepared in 
0 20 , and adjusted to a pD of approximately 10. A 2.9 mol dm-
3 solution of CaCl2 was made 
up in 0 20 , and adjusted to a pD of approximately 10. No precipitate was seen. For each 
scan a 10 µQ aliquot of the calcium solution was added until a two fold excess of calcium had 
been added. 
For the calcium/dtda pD scan a 1 :2 molar ratio of the metal and ligand were dissolved in 0 20 
and adjusted to approximately pD 12. The pD was decreased by the addition of small 
quantities of DCI, and 1H and 13C spectra recorded ~teach pD. The initial concentrations 
were 0.48 Calcium and 0.24 mol dm-3 dtda. 
To obtain the zinc spectra a 1: 1 molar ratio of the metal and ligand were dissolved in 020 
and adjusted to approximately pD 9. The pD was decreased by the addition of small 
quantities of DCI. The initial concentrations were 0.1 mol dm-3 for ttda and zinc. 
In all cases the pD was determined using a combination micro electrode calibrated with 
standard pH buffers . The pD was obtained from the relationship 
























The study of metal ion chemistry in biofluids has several facets . The metal ions are 
intimately associated with many enzyme control processes . However, their transport 
through and between body compartments is often mediated by low molecular weight 
ligands. Examples of this are given by Leigh and Miller, and Forth and Nell (Leigh and 
Miller, 1983; Forth and Nell , 1981). 
Jackson et al have postulated that an increase in the l.m.w. pool of copper stimulates an 
anti-inflammatory response (Jackson, May and Williams, 1978). It is for this reason that we 
have attempted to manipulate this fraction of copper using exogenous ligands. It is of 
interest to assess experimentally the effect of the ligands on the blood plasma speciation 
of copper. Although the actual copper-protein binding constants are not of particular interest 
in this study, some of the techniques used to determine them are. The actual l.m.w. 
distribution is also of little importance, and in any case is extremely difficult to measure 
(Jackson , May and Williams , 1978). It may be assumed , however, that the predominant 
l.m.w. species will be the M-ttda or M-dtda complexes, as the concentration of these ligands 
is considerably higher than that of competing ligands. 
The objectives of this study were two-fold : 
1. To determine experimentally whether the ligands mobilised copper as the l.m.w. 
species, and 
2. To compare the experimental mobilisation curves with those calculated using the 
blood model. 
Also of interest is the effect of the ligands on the zinc and calcium equilibria. Computer 
calculations suggested that interference of the ligands in the zn+2 and ca+2 equilibria would 
be significant. Attempts were therefore made, using ultrafiltration, to quantify the in vitro 
mobilisation of copper from protein . 
5.5.2 Theory 
The reversible interaction between small molecules and macromolecules is fundamentally 
important in biology, and binding experiments have played a major role in elucidating 















method of determining the binding between protein and small molecules has been dialysis 
with gel filtration , chromatography or electrophoresis. These methods can be used to 
identify which proteins bind a specific metal , in what proportions , to what extent, as well as 
how many metal ions bind to each protein and the number of classes of binding site. In this 
study, however, our interest is in determining the extent to which the metal-protein ..,.,, metal-
1.m.w. equilibrium is perturbed ~y our ligands, ttda and dtda. 
With the introduction of semi-permeable membranes which prevent the passage of 
macromolecules, ultrafiltration methods became possible, (Sophianopoulos et al , 1978). 
Two main approaches have been used. In one method the volume of the ultrafiltered 
sample is kept constant by continually adding a solution containing the ligand, for example 
wash in and wash out procedures. In the second method nothing is added to the sample 
being filtered and a small aliquot of filtrate is collected . Generally the second method is 
considered to be approximate , as V0 :::: V0 - dv is assumed, and it is felt that the removal of 
the ultrafiltered liquid , dv, disturbs the equilibrium. Only small quantities, about 1 O %, (Staub 
and Buffle , 1984) are normally removed. 
Sophianopoulos et al (Sophianopoulos et al , 1978) and Gamble et al, (Gamble, Haniff and 
Zienius, 1986) both showed that theoretically the concentration of free ligand (or metal) in 
the ultrafiltrate is the same as that in the initial sample, and is independent of the volume of 
the ultrafiltrate. The method may thus be used to give exact results in binding studies . It 
is assumed that both the ligand and solvent pass unimpeded through the membrane and 
that the macromolecule is completely retained by the membrane. 
At equilibrium the free energy change of a system is given by 
Where µi = The chemical potential , and 
ni = the number of moles of component i 
The reaction at equilibrium is thus completely defined . The effect of removing quantities of 
one of the components , plus solvent, from the reaction mixture can be illustrated by the 
following simple reaction of a single ligand binding to a protein. 












The dissociation constant can be expressed in terms of concentrations as 
K = [P] [A] 
[PA] 
([P rJ - [A rJ + [A]) [A] 
= -~~~~~~~~ 
([Ar] - [A]) 
(5.5.2) 
(5.5.3) 
[Pr] . [Ar] . [P] , [A] and [PA] are the molar concentrations of total protein , total ligand, 
free protein , free ligand and protein-ligand complex, respectively . 
If the moles of the constituents are denoted by m, and the states before and after removal 
of free ligand by (0) and (1) respectively. Let a small amount of freely diffusible ligand, dm, 
be removed at equilibrium such that dmldv = A0 , dv being the accompanying small volume 
change . The equilibrium constants for each state may then be written as 
[mpro - mATo + (dmldv)·V0] ---------·(dmldv) = K 
[mAro - (dm/dv)·V0 ] 
[mpro - mATo + dm +(A1 )·( V0 - dv)] - - ---------·(A1) = K [mAro - dm - (A1)•(V0 - dv)] 
As Ka must equal K1 , equations 4 and 5 must be equal. Thus 
A, = dm/dv = A0 . 
(5.5.4) 
(5.5.5) 
The removal of solution is thus not limited to small amounts of filtrate, as required by the 
assumption 
V0 "' Va - dv 
and the concentration of the ligand in the ultrafiltrate is equal to that in the initial solution. 
Although the above illustration was for the simple case of one ligand binding to the protein 
molecule, it may be extended to the general case for ni ligand molecules binding to .sites of 
equal affinity and i sites of different affinities . The parameter v, defined as the number of 












v = (6) 
In the simple case considered above, i = j =nj = 1. However, (A) is the only variable, and if 
(A) is constant, then vis also constant, and the theory applies to the general case. 
5.5.3 Results and discussion 
The calculated and experimental P.M.I. curves for copper, obtained by plotting log P.M.I. 
against the log of the ligand concentration , are given in Figures 5.5.1 and 5.5.2 respectively. 
There is a considerable difference between the two sets of curves . The most obvious 
difference is the slope of the lines, with the calculated curves having a much steeper slope. 
Experimental limitations did not allow very low concentrations to be used in the ultrafiltration , 
but if the experimental lines are extrapolated , then the concentration at wh ich the 
mobilisation starts is of similar order of magnitude to the calcu lated value. The accuracy of 
the extrapolated value from this data is likely to be low, however. The order of the mobi lising 
ability of the ligands is similar in both the calculated and experimental curves . The fact that 
the experimental curves have different slopes makes the determination of the order 
somewhat subjective, but the following order seems reasonable . 
ttda > dtda > edda > dtpa > edta "' trien 
The calculated order is: 
trien > ttda > dtda > edda > dtpa > edta 
The low mobilising ability of edta and dtpa can be understood in terms of competition from 
zinc and calcium , both of which are present in high concentrations in blood plasma. 
Compared to the other ligands studied , edta and dtpa have relatively large Ca(ll) and Zn (ll ) 
formation constants, and this i,n effect limits the availability of these ligands for interaction 
with copper(ll) . The converse appl ies to trien , which has very little affinity for Calcium. The 
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Figure 5.5.2: Experimental copper P.M.I. curves for ttda , dtda, edda, dtpa, edta and trien. 
The calculated and experimental zinc P.M.I. curves for the ligands are given in Figures 5.5.3 
and 5.5.4 respectively . 
As with the results of the copper studies, it is difficult to unequivocally determine the order 
of mobilising ability of the ligands from the experimental results, but extrapolating and using 
the intercept where log P.M.I. is zero, the following order was established. 












The ca lculated order is 
ttda "" dtda "" dtpa > edda > edta > trien 
Experimentally dtpa was found to be more effective than predicted from the blood model 
simulation . The order for edda and edta was reversed and there seems no ready 
explanation for th is observation , but has been report previously (Jackson and Singh , 1990). 
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Figure 5.5.4: Experimental zinc P.M.I. curves for ttda, dtda, edda, dtpa , edta and tri en. 
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While'the model fails to predict some of the finer details of the experimental results , several 
aspects were successfully modelled. The general order of mobilisation is predicted , as is 
the approximate onset of mobilisation. 
5.5.4 Experimental 
Human blood serum was obtained from the Western Province Blood Transfusion Service 
and stored at -4°C. Dtpa (Merck) , edta (NTA) and edda(Sigma) were used without further 
purification. Trien (Merck) was purified by distillation under reduced pressure and fractional 
crystallisation of the hydrochloride (Sacconi, Paolletti and Ciampolini, 1961 ). Accurately 
weighed masses of ligand were added to 10 ml aliquots of serum at pH 7.4. The solutions 
were incubated for 15 minutes at 37°C to allow them to reach equilibrium and then 
ultrafiltered. Centrifugal pressure at 300 rpm (- 900 g) allowed a filtration rate of 1 O,um min-1 
through YMT (Amicon) membranes to be achieve~. The ultrafiltrates were analysed for 
copper, zinc and calcium by atomic absorption spectrometry. Calcium was measured using 
a N20/C2H2 flame at 422,7 nm. A 100 fold excess of lanthanum nitrate was added to each 
of the samples to suppress ionisation of the analyte. Zinc was measured at 213,9 nm using 
an oxidising air/C2H2 flame. Copper was measured on a Perkin Elmer 5000 AA 
spectrophotometer using a graphite furnace coupled to a HGA 500 programmer. 
The theoretical plasma mobilisation indexes were obtained using the blood simulation 
























In the initial development of any drug, the use of in vitro methods can be advantageous. Not 
only is this approach more convenient, but the experimentation is generally more 
reproducible and does not have the moral considerations inherent in animal screens. 
Ultimately though , if the in vitro experiments ind icate potential , in vivo testing , using an imal 
screens , is unavoidable. 
The aim of this study was to design, using computer simulation (Jackson and Kelly , 1988), 
a ligand which would be an effective mobilizer of copper (May and Williams , 1981 ). To 
assess whether this ligand was in reality a good copper mobilizer, the solution 
thermodynamics of the ligand and several biologically important metal ions, including copper, 
were studied using potentiometric techniques. This data allowed the mobilizing efficiency 
of the ligands to be assessed, using the plasma ~_imulation model. The results of this 
simulation predicted that (a) the copper would be strongly mobil ized and (b) that the 
perturbation of the other metals present would not be unacceptably high in vivo . These 
conclusions were supported by ultra filtration studi s, Section 5.5. Further, the pH 
dependent species distribution plot, Figure 5.6.1 , shows that at the physiological pH of 7.4 , 
the Cu-ttda complex is the only important species . 
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As this species is nominally neutral, it should be effectively transported through the cell 
membrane. This property is required for transport of the copper from one body compartment 
to another. (Sarkar, 1981). Lipophilicity would undoubtedly be enhanced if the two 
carboxylate residues on the ttda molecule were coordinated . The variable pH UVNIS study 
indicated that the carboxylate residues were complexed to the copper. 
In summary, the following positive in vitro results were obtained. 
a) Ttda is an effective Copper(l I) mobilizer. 
b) Ttda is relatively selective for Copper(ll). 
c) The major species at physiological pH is neutral. 
d) This complex appears to be six coordinate, which will increase its lipophilicity, and 
thus be more membrane soluble . 
These results , together with the reported success of copper complexes as anti-inflammatory 
agents in animal tests , indicated that animal screens were warranted. 
The questions of interest were • 
a) Is the Cu(ll )-ttda complex active as an anti-inflammatory? 
b) How effective is it? 
c) Is membrane transport efficient? 
d) What is the toxicity of the complex ? 
Rat adjuvant arthritis was chosen as the most appropriate model of inflammation (Meyers , 
1988) . This model is considered to closely resemble rheumatoid arthritis in humans and 
allows administration of the compound during the established phase of the disease (Lewis 
and West, 1981). 
Initial dosages were based on earl ier studies (Jackson , May and Williams, 1978; Lewis and 












5.6.2 Results and Discussion 
Although some aspects of these animal screens were unsatisfactory, some of the 
information gained allows important conclusions to be drawn regarding the in vivo behaviour 
of the test complex. Figure 5.6 .2 shows the comparative paw sizes of the inflamed and 
uninflamed paws. 
Figure 5.6.2: Comparative sizes of inflamed and uninflamed paws. 
The average paw volume of the rats which received the complex, group 1, is presented in 
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Figure 5.6.4. Average paw volume, group 2 
6 28 
The condition of the animals which received the copper chloride, group 2, started to 
deteriorate on the second day, thus it was not realistic to administer further doses. The 
animals started to die on the third day after injection and by the seventh day, all five were 
dead. There was no sign of reduction in the volume of the paw. By the time they died, the 
longest surviving animals had developed lesions at the site of injection. This copper induced 
irritation has been noted by other workers (Lewis, 1978; Lewis, Smith, and Brown, 1978). 
The animals in group 1 showed no sign of ill health. There was no noticeable reduction in 
the inflammation. Unlike the group 2 animals, these rats did not show any sign of irritation 
at the site of injection. 
It has been reported (Lewis A.J., 1978; Sorenson, 1976; Lewis and West, 1981) that copper 
aspirinate possesses anti-inflammatory activity when tested with this model , so this complex 
was used as the control instead of copper chloride. Copper aspirinate was therefore 
administered at the same copper concentration as the test complex (group 5) . Once again 
the condition of the animals immediately started to deteriorate. Within 3 days, four of the 
animals had died. The surviving animal's condition did not return to normal with time. This 
animal developed a lesion at the site of injection similar to those of the group 2 animals . 
The group 4 animals, those receiving the test complex, also showed signs of discomfort the 
day after the high dose of 15 mgkg-1 was given. For this reason , a further dose was not 
given on the second day. Increased dosing was achieved by giving 1 Omgkg-1 every day. 












Previo'usly it has been noted (Whitehouse, 1976; Rainsford, and Whitehouse , 1979; Lewis, 
Smith and Brown, 1978) that subcutaneous injection of copper complexes often produces 
a local irritant response. Rainsford and Whitehouse ( Rainsford and Whitehouse, 1979) 
have suggested that the observed anti-inflammatory activity of the complexes is the result 
of a counter irritant mechanism, as these compounds were not active when administered 
orally. However, Banta and Nordhoek (Banta and Nordhoek, 1973) have demonstrated that 
irritation does not always reduce inflammation in an induced model. In this study, those 
animals which developed lesions, did not show any signs of inflammation reduction . 
A J Lewis (Lewis, 1978), Sorenson (Sorenson, 1976) and E J Lewis (Lewis, 1981) report 
anti-inflammatory activity of copper aspirinate with various models of inflammation. The 
death of the animals after copper chloride and copper aspirinate administration was 
unexpected, as Sorenson gives an L050 for copper aspirinate of 750mgkg-
1 and 350mgkg-1 
for copper acetate, administered subcutaneously. Jackson et al (Jackson, May and 
Williams , 1978) reported that a dose of 9.3mgkg-1 copper, as the chloride, was effective in 
the inhibition of a Carrageenan-induced oedema model of inflammation. No mention was 
made of animal mortality. Lewis et al (Lewis, Smith and Brown , 1981) report that after 
receiving a single dose of 238mgkg·1 copper aspirinate, all the animals injected died. The 
doses used in this study are substantially lower than those reported above. It has been 
suggested (Brown and Smith , 1980; Pharo, 1988) that the strain used may be sensitive to 
high levels of exogenous copper. The animals which received the test complex did not 
generally show any signs of discomfort. The only exception was group 4, after receiving a 
1 Smgkg-1 dose. These animals did not show any discomfort or stress when the dosage was 
reduced to 1 Omgkg-1 every day for 3 days. A possible explanation for this is that the toxic 
effects of the copper are reduced by complexation (Lauffer, 1987) although it is also a 
possibility that the ligand merely promotes the excretion of the copper. 
The route of excretion from the body is in some measure dependent on the complex itself. 
Charged complexes are readily excreted in the urine, via the kidneys , while uncharged 
species are often metabolized by the liver, and excreted in the faeces. In order to test for 
the excretion of our test compound , urine samples were collected , at different times, from 
the group 4 animals . The urine was analysed for total copper by graphite furnace atomic 
absorption spectrometry and for the [Cu(ttda)] complex spectrophotometrically. The results 












Table 5.6.1.: · Quantities of copper determined in the rat urine. 
Sample Cuc by UV 
mg per % of Cua 
animal 
0-1 hr 1.4 27% 
0-24 hrs 2.27 32% 
24-48 hrs 0 
Cuc = Cu2+ present as the complex 
Cur = total Cu2+ present in all forms 
Cua = Cu2+ administered to the animal 
Cur by AA 










Figure 5.6.5: Colours of the injected solution and 3 urine samples . From left to right, injected 
solution , 0-1 hour urine sample, 0-24 hour urine sa'mple and 24-48 hour urine sample . 
Note the intense colour of the sample collected after 1 hour and its similarity to the injected 
sample. The concentrations of copper detected by UV were approximately 6% lower than 












complex while atomic absorption measures the total copper concentration, this 6% difference 
represents the other forms of copper present in the urine. These other forms of copper may 
be inherent to the urine or be a result of contamination by faeces, food particles or dust. In 
both cases though, the analysis showed that the same % of administered copper was 
excreted in the first hour as in the first 24 hours . It is unlikely that this is a coincidence, and 
indicates that the compound is excreted through the urine only when there is a very high 
complex concentration in the blood. That is, immediately after the injection. Only an 
extremely low concentration of copper was detected in the 24-48 hour sample. Analysis of 
the faeces could have shown conclusively whether the copper was being excreted or retained 
in the body, but this analysis was not possible . 
It has been suggested, from histological evidence, that the model developed in the animals 
was inadequate (Wainwright, 1988). Sharma et al (Sharma, Chandra and Basu, 1987) 
indicate destruction of tissue due to the release of lysosomal enzyme, as well as destructive 
lesions in the tarsals or metatarsals. Although the animals in this study did show extensive 
tissue damage, the effect on the bone and joint tissue was minimal. Difficulty was 
experienced in initiating the model. It is also well known that animal tests are sensitive to 
factors such as the species used, route of administration and time scale. All these variables 
may have contributed to the largely inconclusive results obtained for the anti-inflammatory 
activity. 
5.6.3 Conclusion 
The results of these experiments indicate that for this strain of rat the presence of the ligand 
appreciably decreases the toxicity of the copper. The rapid appearance of the copper 
complex in the urine suggests that while the complex is able to pass into the blood stream 
from the site of injection, it is too hydrophilic to be completely reabsorbed into the blood 
stream from the kidneys. For transport of the copper from one body compartment to another, 
neutral complexes, (Jackson, May and Williams, 1978; Sarker, 1981) will enhance metal ion 
diffusion across the cell membrane as they are relatively lipophilic. 
The detection of 36% of the total administered copper in the urine also suggests that the 













There is a need to further develop the animal model used, as well as to try to duplicate other 
published results. The indications are, however, that this approach to anti-inflammatory drug 
design is well worth pursuing . 
5.6.4 Experimental 
Two sets of screens were conducted. 
1. A dose of 1 O mgkg·1 copper was administered , as the complex, to one group, group 
1, and as the chloride to another, group 2. A placebo (saline) was administered to a 
t11ird group, group 3. The administration of the complex was repeated every second 
day for 2 doses. Only one dose of copper chloride was administered as the condition 
of the animals had deteriorated by the second 9ay. The paw size was measured after 
each injection and inspected every day for signs of inflammation reduction . 
2. The dose profile of the complex was increased to an initial dose of 15 mgkg-1 copper 
(group 4). A day was skipped as the animals showed signs of discomfort, and dosing 
at 10 mgkg-1 per day was then continued for 3 days. 15 mgkg-1 copper, as the 
aspirinate mixture , was given to a second group (group 5) . Nothing further was given 
as the condition of the animals started deteriorating immediately. Paw volume was 
monitored as above. 
Exact quantities for the various doses are given in Table 5.6.1 below. 
Table 5.6.1: Doses of copper compounds administered to the rats . 
Masses taken Dose Volume 
ligand (g(mmol)) CuCl2.2H20 complex copper( II) total (ml) per rat (ml) 
(g(mmol)) (mgkg-1) (mgkg-1) 
ttda (group 1) 0.232(0.568) 0.096(0.567) 52 10 22.68 3.2 
Cl (group 2) - 0.096(0.567) - 10 22.68 3.2 
ttda (group 4) 0.348(0 .353) 0.144(0.844) 73 14 34.02 4.5 












Paw volumes were measured using an instrument designed and constructed in this 
laboratory, and is shown in Figure 5.6.6. 
Constant bore measuring cylinder 
Clear perspex block 
Approximate scale: 2 cm 
Figure 5.6.6: Apparatus used to measure paw volumes . 
The graduations are constant, but the units are arbitrary. No attempt was made to calibrate 
-
the instrument as the error in the graduation was small relative to other sources of error. The 
"cylinder" was filled to a convenient level with a very dilute solution of ink. The colour aided 
in the determination of the position of the meniscus. The rat's hind ankles were ringed , using 
an indelible dye. The paws were measured sequentially, and the position of the meniscus 
noted before immersion, and when the meniscus just touched the ring . Determining when 
the meniscus touched the mark was the largest source of error in the measurement, and was 
of the order of 5%. It was necessary to anaesthetize the animal both for the injection and the 
measurement. The compounds were administered subcutaneously. 
The urine from the animals receiving the test complex was collected using metabolic cages 
as follows : 
a) For 24 hrs immediately following the first injection of 15 mgkg·1 copper, i.e. 
day 1 of the experiment. 
b) The following 24 hours, i.e . day 2 of the experiment. 













The urine was frozen as soon as possible after the samples were collected. Precipitate 
formed in samples (a) and (b) on storage. The samples were analysed by UV spectroscopy, 
for complex concentration on a Philips PU8700 UV/vis spectrophotometer. A base line 
adjustment was made to accommodate for the absorption due to normal urine components. 
AA analysis by graphite furnace on a Pye Unicam was performed to determine total copper. 
The samples containing precipitate were first digested with concentrated HN03 (Aristar, 
spectroscopically pure) to solubilize the solid . 
Post mortems were performed on groups 1 - 4, immediately after they died or were culled at 
the end of the screen. 
Copper(ll) chloride dihydrate, sodium chloride and sodium hydroxide were obtained from 
SAARCHEM Ltd and were of analytical grade. Acetyl salicylic acid (aspirin) was obtained 
from BDH and was of reagent grade. Ttda tetrahydrochloride was synthesized in this 
laboratory. Solutions were made up in glass distilled water and then passed through a 
millipore microfilter (cat. No. SLGS 0250S) to remove microorganisms. Male Sprague-Dawley 
rats , from an inbred colony, weighing between 450 and 500 grams were used. The animals 
were divided into groups of 5, and were fed on standard rat cubes. 
Adjuvant arthritis was induced by injecting Freud's complete adjuvant (0.5 ml) into the right 
hind paw pod. Attempts to induce the arthritis by injecting into the base of the tail failed. The 
inflammation was allowed to develop for 14 days at which time the experiment was started. 
Paw volume was monitored daily, with the animal's uninflamed left rear paw being used as 
a control for that animal. 
Solutions of Cu(ll)-ttda for injection were prepared by dissolving an appropriate quantity of 
ttda and CuCl2 in a volume of water calculated to give a solution with a total NaCl 
concentration of 0.15M. The pH of the solution was adjusted to 7.4 using concentrated 
sodium hydroxide. The selected dose was administered by injecting a specific volume of 
solution , calculated on the mass of the animal. The copper chloride solutions were prepared 
by dissolving the required amount of copper(ll) chloride, plus sufficient NaCl to give a final 
concentration of 0.15M, in the correct volume of distilled water. The pH was left unadjusted 
at about 5.5. The copper aspirinate solution was made by preparing separate solutions of 
copper(ll)chloride and aspirinate. The pH of the aspirinate solution was raised to 
approximately 5 to dissolve the compound . The solutions were mixed just prior to injection, 
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The urine was frozen as soon as possible after the samples were collected . Precipitate 
formed in samples (a) and (b) on storage. The samples were analysed by UV spectroscopy, 
for complex concentration on a Philips PU8700 UV/vis spectrophotometer. A base line 
adjustment was made to accommodate for the absorption due to normal urine components. 
AA analysis by graphite furnace on a Pye Unicam was performed to determine total copper. 
The samples containing precipitate were first digested with concentrated HN03 (Aristar, 
spectroscopically pure) to solubilize the solid . 
Post mortems were performed on groups 1 - 4, immediately after they died or were culled at 
the end of the screen . 
Copper(!!) chloride dihydrate, sodium chloride and sodium hydroxide were obtained from 
SAARCHEM Ltd and were of analytical grade. Acetyl salicylic acid (aspirin) was obtained 
from BDH and was of reagent grade. Ttda tetrahydrochloride was synthesized in this 
laboratory. Solutions were made up in glass distilled water and then passed through a 
mi Iii pore microfilter(cat. No. SLGS 0250S) to remove microorganisms. Male Sprague-Dawley 
rats , from an inbred colony, weighing between 450 and 500 grams were used. The animals 
were divided into groups of 5, and were fed on standard rat cubes . 
Adjuvant arthritis was induced by injecting Freud's complete adjuvant (0 .5 ml) into the right 
hind paw pod. Attempts to induce the arthritis by injecting into the base of the tail failed . The 
inflammation was allowed to develop for 14 days at which time the experiment was started. 
Paw volume was monitored daily, with the animal's uninflamed left rear paw being used as 
a control for that animal. 
Solutions of Cu(ll)-ttda for injection were prepared by dissolving an appropriate quantity of 
ttda and CuCl2 in a volume of water calculated to give a solution with a total NaCl 
concentration of 0.15M. The pH of the solution was adjusted to 7.4 using concentrated 
sodium hydroxide. The selected dose was administered by injecting a specific volume of 
solution, calculated on the mass of the animal. The copper chloride solutions were prepared 
by dissolving the required amount of copper(!!) chloride, plus sufficient NaCl to give a final 
concentration of 0.15M, in the correct volume of distilled water. The pH was left unadjusted 
at about 5.5. The copper aspirinate solution was made by preparing separate solutions of 
, 
copper(ll)chloride and aspirinate. The pH of the aspirinate solution was raised to 
approximately 5 to dissolve the compound . The solutions were mixed just prior to injection, 
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The stability constants determined for the two ligands (Chapter 4) were used as input into 
the simulation program, and the copper P.M.I. curves for the two ligands generated. These 
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Figure 6.1 : Copper(ll) P.M.I. curves for ttda , dtda, trien , edda and dtpa 
The simulation indicates that although ttda forms more stable complexes with copper than 
trien , it is less efficient than trien at mobilising copper. This demonstrates the importance of 
the other complex equilibria in plasma in determining the copper P.M.I. The reason for 
greater copper mobilisation by trien is high concentration of zinc in the blood, and the 
relative stability of the zinc and copper complexes . For edta the higher concentrations of 
zinc and calcium and the relatively strong complexes formed render this ligand an ineffective 
copper plasma mobiliser. 
P.M. I. curves were computed for ttda and dtda with copper(ll) , nickel(ll) and zinc(ll) . These 
curves are presented in Figure 6.2 and indicate that the ligands will cause some 
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Figure 6.2: Computed P.M.I. curves for ttda and dtda with copper(ll), nickel(ll) and zinc(ll) 
At a ligand concentration of 10-3 the calcium(ll) P.M.I. is less than 0.01, and should thus 
have little effect on the in vivo calcium (II) distribution. The results of this simulation show 
that ttda and dtda should be good mobilizers of copper in blood plasma. The prediction of 
the relative effectiveness of the two ligands by the model is interesting, in that dtda is shown 
to be slightly more effective than the more stable ttda complex. 
The mobilisation calculations are in general supported by the results of the plasma 
ultrafiltration studies and confirm the validity of the model , although there are some 
limitations associated with the model , particularly concerning protein interactions. The 
predicted higher copper mobilisation by dtda is not seen experimentally. It is possible that 
this is due to interactions of the ligands with the protein . The success of the ultrafiltration 
confirms that the ligands survive in the conditions prevailing in plasma. 
The species distribution of ttda , as calculated in the simulation for a total concentration of 
1x10-5 , in plasma is mainly between the zinc complex, and the monoprotonated free ligand. 
The percentage distribution amongst the complexes placed in the model is given in Table 
6.1 for ttda and Table 6.2 for dtda. The calculated concentrations depend on the total 












Table 2.1: ·Distribution of ttda amongst the input complexes as predicted by the blood plasma 
model. The complexes are given in decreasing order of concentration , calculated for 
a total ligand concentration of 1 o-5M. 
I 
Table 6.2 : 
I 
Com el ex I Concentration I . Percent Formation I 
Znttda 9.982 x 10-5 99.8 
ttdaH 2 1.423 x 10-a 0.1 
ttdaH 3 1.275 x 10-
9 0.0 
[ZnttdaHr 1.234 x 10-9 0.0 
ttdaH 5.264 x 10-10 0.0 
Nittda 8.694 x 10-11 0.0 
Cuttda 4.889 x 10-11 0.0 
Cattda 3.735 x 10-12 0.0 
Mgttda 2.542 x 10-13 0.0 
ttdaH 4 7.038 x 10-
14 0.0 
[CuttdaHr 7.435 x 10-15 0.0 
Mnttda 6.595 x 10-15 0.0 
[CattdaQH-] 4.095 x 10-16 0.0 
[MgttdaOH-] 8.574 x 10-17 0.0 
ttdaH 5 7. 754 x 10-
20 0.0 
[CuttdaH?]2+ 1.672 x 10-20 0.0 
Distribution of dtda amongst the input complexes as predicted by the blood plasma 
model. The complexes are given in decreasing order of concentration , calculated for 
a total ligand concentration of 1 o-5M. 
Com el ex I Concentration I Percent Formation I 
Zndtda ,. 8.755 x 10-5 87.6 
dtdaH2 1.139 x 10-
5 11.4 
dtdaH 1.034 x 10-7 1.0 












I Com~lex I Concentration I Percent Formation I 
dtdaH3 8.099 x 10·
10 0.0 
Cadtda 2. 788 x 10·10 0.0 
Mgdtda 1.225 x 10·10 0.0 
Cudtda 5.398 x 10·11 0.0 
Nidtda 1.829 x 10·11 0.0 
[CadtdaOH]' 4.713 x 10·14 0.0 
Mndtda 2.411x10·14 0.0 
[CudtdaOH]' 1.175 x 10·14 0.0 
dtdaH4 4.271 x 10·
15 0.0 
[CudtdaHr 4.114 x 10·15 0.0 
rNidtdaHr 6.828 x 10·11 0.0 
The order given for the various complexes demonstrates their relative stability under the 
concentration parameters given in the blood model. Although the concentrations calculated 
are dependent on the total concentration given for the ligand, they do serve to illustrate the 
large differences in concentration of the resulting complexes . Of note is the large difference 
in the concentrations of the zinc and copper complexes for both the ligands. Due to the 
large differences in free metal concentrations , these figures indicate that a therapeutic using 
either of these ligands would require some countermeasures to be taken to reduce the effect 
on the zinc balance. A possible counter to the zinc disturbance would be to administer the 
ligand as the zinc complex, which is the approach used with dtpa which is administered as 
the calcium complex (Jackson and Jarvis, 1995). 
A second aspect that needs to be cons idered with the distribution of the metal , is the specific 
complex with which it is associated. The concentrations given in Tables 6.1 and 6.2 above 
are calculated at the pH of blood, approximately 7.4 , and the major complexes for copper 
and zinc are found to be neutral species . This form is most likely to be transported into 
tissue (Neumann and Silverberg , 1966). Very little of either metal is present as charged 
,complexes , in which form it would be excreted through the kidneys . 
Confirmation of the bonding of the negative carboxylic groups is thus important. The 
ultrafiltration measurements determined total l.m.w. copper only, with no information 












the six co-ordinated Cu-ttda complex is the major species present in solution . The Zn-ttda 
n.m.r. results also indicate that the acetate residues are co-ordinated to the metal. On this 
evidence it is to be expected that the copper complex should possess a relatively high 
degree of lipophilicity, which should facilitate transport across the biological membrane. 
The species concentration distribution curves for the ttda-Cu2+ and dtda-Cu2+ systems are 
given in Figures 6 .3 and 6.4 . 
.......... 
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Figure 6 .3: Species concentration distribution for the Cu(ll)-ttda system, with a ligand to metal 
concentration ratio of 1. Total [Cu(ll)] = 1.6 mM = Total [ttda) 
At the pH of the stomach , approximately 2, the proportion of the neutral [Cu(ttda)) formed 
is very small. With dtda the neutral complex forms a much higher proportion , but it is still 
very low. From this data it can be expected that most of the absorption will take place in the 
intestine, rather than the stomach . At the stomach pH the mono- and diprotonated copper 
complex species predominate , bu t most of the ligand is present as a copper complex of 
some form. A large proportion of the ligand is present in the LH3 and LH4 form , and may not 












through conversion to the lactam, which is a known degradation reaction with these ligands 
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Figure 6.4: Species concentration distribution for the Cu-dtda system, with a ligand to metal 
concentration ratio of 1. Total [Cu(ll)] = 1.6 mM = Total [dtda] 
The nickel(ll) P.M.I. curve, Figure 6.2, suggests that these ligands could be useful as drugs 
in chelation therapy for nickel(ll) poisoning. The indication given by the model is that ttda is 
10 times more effective at mobilising nickel(ll) than copper(ll). There is a marked decrease 
in the relative mobilising ability of the Ni-dtda complex when compared to the Ni-ttda 
complex. 
The conclusions derived from the computer simulation support the use of the two target 
ligands as copper mobilisation drugs, and suggest that they have potential as anti-
inflammatory therapeutics. Studies of a more biological nature were undertaken to 
supplement the modelling and chemical work. 
The results of the SOD activity simulation test demonstrated minimal superoxide dismutase 












chloroquine and azathioprine (Roberts and Robinson, 1985) are also inactive. An 
explanation for this is that alternative mechanisms of relief may also be present. Roberts 
et al ( Roberts and Robinson, 1985) note that ethylenediamine di acetic acid ( edda) is active 
in this test. As dtda and ttda are very close structurally to edda, it is surprising that ttda has 
such a low activity level. 
In undertaking animal screens it was hoped that clear indication of any anti-inflammatory 
action would be obtained. The failure to successfully develop the adjuvant arthritis model 
leaves this question unanswered , but does provide some information on how the complex 
responds in animal systems. 
When the irritation caused by the copper chloride and copper aspirinate injections is 
considered , it is certain that the complex survives in vivo as this explains the absence of 
irritation at the site of the injection. The high concentration of copper in the one hour urine 
sample could be an indication that the complex is charged , and hence has a high degree of 
hydrophilicity . Although the complex is nominally neutral, it could also be polar, with the 
carboxylate groups uncoordinated. One aspect of the data gathered which does not support 
this hypothesis is the absence of a marked increase in the copper concentration in the 24 
hour urine , sample. 
In subsequent work (Voye, 1993), 67Cu was used to study the bio-distribution of several 
ligands, including ttda and dtda, in mice. The results confirmed the high excretion via the 
urine, 72% of the dose in the first 24 hours in the case of ttda . The bio-distribution showed 
small quantities of copper retained in the liver, blood and kidneys. When compared to the 
CuCl2 control , it was apparent that the ttda and dtda copper(ll) complexes were stable in 
vivo. 
In summary , the ligands designed by use of the blood plasma model , ECCLES, were 
successfully synthesised. The formation constants measured using potentiometric 
techniques were added to the ECCLES data base and the copper (II) mobilisation calculated . 
The calculated P.M.I. curves were compared to experimental curves obtained by 
ultrafiltration techniques. The trends demonstrated by the calculated and experimental 
curves were largely in agreement. Animal screens using the adjuvant arthritis model were 
unsuccessful , as the model was not correctly induced. The results of bio-distribution studies 
using these ligands , and the high concentration of copper measured in the urine, it is unlikely 
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Adjusted formation constants used in the ligand design in Chapter 2. The subscripts pqr 







4-oxa-1, 7, diazaheptane H+ Po11 9.45 
Po12 18.18 
Mg+2 P110 0.30 
ca+2 P110 0.20 
Mn+2 P110 2.00 
P120 3.40 
Ni+2 P110 5.50 
P120 8.77 
.-cu+2 P110 8.50 
P120 12.59 
p,,_, 18.65 
zn+2 P110 5.57 
P120 9.43 
p,,_, 18.57 
4-thia-1 , 7-diazaheptane H+ Po11 9.29 
Po12 17.78 
Mg+2 P110 0.20 
ca+2 P110 0.20 
Mn+2 P110 2.00 
P120 3.40 
Ni+2 P110 7.39 
P120 12.98 
cu+2 P110 8.83 
P120 13.83 
p,,_, 19.22 





















iminobis(2-ethylamine) H+ Pa11 9.52 
Pa12 18.22 
Pa13 22.29 
Mg+2 P110 0.60 
ca+2 P110 0.50 
Mn+2 P110 3.94 
P120 6.71 
N(2 P110 10.15 
P120 17.86 
cu+2 P11 0 15.37 
P1 20 20.14 
P11 1 3.25 
P112 13.30 
P1 1-1 17.80 
zn+2 P110 8.61 
P120 13.82 




Mg+2 ~1 10 0.40 
ca+2 P110 0.30 
Mn+2 P11 0 3.50 
Ni+2 P110 9.70 
cu+2 P110 12.64 



















N, N' -bis(2-imidazolylmethyl)ethylenediamine H+ Pa11 9.52 
Po12 18.22 
Po13 22.29 
Mg+2 P110 0.60 
ca+2 P110 0.50 
Mn+2 P110 3.94 
P1 20 6.71 
Ni+2 P1 10 10.15 
P1 20 17.86 
cu+2 P110 15.37 
P1 20 20.14 
P, ,, 3.25 
P112 13.30 
p,,_, 17.80 
zn+2 P110 8.61 
P120 13.82 
N, N'-bis( 4-imidazolyl methyl)ethylenediamine H+ Po11 9.52 
Pa12 18.22 
Pa13 22.29 
Mg+2 P110 0.60 
ca+2 P110 0.50 
Mn+2 P110 3.94 
P120 6.71 
Ni+2 P110 10.15 
P120 17.86 

























N, N'bis(2-pyridylmethyl)-1 ,2-diaminoethane H+ Pa11 7.94 
Pa12 13.10 
Mg+2 P110 0.80 
ca+2 P110 0.60 
Mn+2 P110 5.48 
Ni+2 P110 13.98 
cu+2 P110 16.49 
zn+2 P110 10.80 




Mg+2 P110 0.80 
ca+2 P110 0.60 
Mn+2 P110 4.86 
Ni+2 P110 13.46 
P120 17.87 
P23o 36.09 
cu+2 P110 19.51 
P111 22.99 
P11-1 24.02 
























Mg+2 P110 0.80 
ca+2 P110 0.70 
Mn+2 P11 0 6.87 
Ni+2 P110 17.78 
P,,, 21 .28 
cu+2 P110 21.22 
P111 26.17 
.-zn+2 P110 15.73 
P,,, 18.47 




Pa1s 33 .16 
Mg+2 P110 1.05 
ca+2 P110 0.90 
Mn+2 P110 6.44 
Ni+2 P110 16.84 
P,,, 20.84 
P112 23.74 
cu+2 P110 22.06 
P111 27.16 
P112 30.89 
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Mg+2 P110 0.80 
ca+2 P110 0.70 
Mn+2 P110 6.30 
Nt2 P110 19.20 
cu+2 P110 20.85 
zn+2 P110 13.71 
P111 15.71 
Ammonia .·H+ Po11 9.52 
Po12 18.22 
Po13 22 .29 
Mg+2 P110 0.60 
ca+2 P110 0.50 
Mn+2 P110 3.94 
P120 6.71 
Ni+2 P110 10.15 
P120 17.86 

























ethylenediamine H+ Po11 9.51 
Po12 16.31 
Mg+2 P110 0.25 
ca+2 P110 0.20 
Mn+2 P110 2.66 
P120 4.62 
Nt 2 P110 7.05 
P120 12.90 
P13o 16.73 
cu+2 P110 10.14 
P120 18.90 
--zn+2 P110 5.50 
P120 10.28 
P130 12.12 




Mg+2 P110 0.65 
ca+2 P110 0.55 
Mn+2 P110 4.51 
Ni+2 P110 10.10 
cu+2 P110 16.47 























Mg+2 P110 0.70 
ca+2 P110 0.60 
Mn+2 P110 3.94 
Ni+2 P110 14.09 
P111 19.51 
cu+2 P110 20.98 
P111 24.42 
.-zn+2 P110 10.91 
Pm 17.07 
P11-1 17.39 
Ethylenebis(iminomethylenephosphorous acid) H+ Po11 7.80 
Po12 12.64 
Mg+2 P110 0.70 
ca+2 P110 0.50 
Mn+2 P11 0 2.70 
Ni+2 P110 7.24 
cu+2 P110 10.32 



















Ethylenebis(iminomethylenephosphonic acid) H+ Po11 10.18 
Po12 17.50 
P013 23 .05 
Po14 27.48 
Mg+2 P110 3.50 
ca+2 P110 3.00 
Mn+2 P110 6.92 
Ni+2 P110 11 .19 
P111 16.56 
Pm 21.41 
cu+2 P110 16.77 
P111 21 .30 
Pm 24.99 
zn+2 P110 10.00 
P111 15.50 
Pm 20.50 




Mg+2 P110 3.95 
ca+2 P110 2 .85 
Mn+2 P110 6 .87 
Ni+2 P110 13.52 
cu+2 P110 15.66 
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Figure 4.44: Species distribution curves for [Mg(dtda)];Total [Mg(ll)] = 1.6 mM =Total [dtda] 
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